Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
J Infect
    September 2022
  1. HUANG J, Xia L, Zhao Y, Wu X, et al
    Coronavirus disease 2019 vaccination and live birth outcome after fresh embryo transfer.
    J Infect. 2022 Sep 26. pii: S0163-4453(22)00552.
    >> Share

  2. AO G, Li A, Wang Y, Tran C, et al
    The effect of SARS-CoV-2 double vaccination on the outcomes of hemodialysis patients with COVID-19: a meta-analysis.
    J Infect. 2022 Sep 26. pii: S0163-4453(22)00553.
    >> Share

  3. YIN Y, Lin J, Yuan S, Tong S, et al
    A booster shot of vaccine against SARS-CoV-2 should be rigorously promoted and implemented in China.
    J Infect. 2022 Sep 25. pii: S0163-4453(22)00546.
    >> Share

  4. CHOI MJ, Choi JY, Hyun H, Nham E, et al
    Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: comparison between prior SARS-CoV-2-infected and infection-naive individuals.
    J Infect. 2022 Sep 23. pii: S0163-4453(22)00548.
    >> Share

  5. YAN F, Gao F
    RBD-ACE2 binding properties in five SARS-CoV-2 variants of concern with new perspectives in the design of pan-coronavirus peptide inhibitors.
    J Infect. 2022 Sep 14. pii: S0163-4453(22)00541.
    >> Share

  6. XU QY, Zheng XQ, Jia ZJ, Wu MJ, et al
    Developing new COVID-19 vaccine against the variants is urgently needed rather than boosters: A longitudinal cohort study.
    J Infect. 2022 Sep 12. pii: S0163-4453(22)00539.
    >> Share

  7. MOUSSAOUI ME, Desmecht S, Tashkeev A, Lambert N, et al
    Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naive people living with HIV.
    J Infect. 2022 Sep 9. pii: S0163-4453(22)00534.
    >> Share

  8. ATTI A, Insalata F, Carr EJ, Otter AD, et al
    Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: a nested case-control within the SIREN study.
    J Infect. 2022 Sep 8. pii: S0163-4453(22)00535.
    >> Share

  9. WONG LSY, Loo EXL, Huang CH, Yap GC, et al
    Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies.
    J Infect. 2022 Sep 3. pii: S0163-4453(22)00515.
    >> Share

  10. SHI T, Dai M, Liu F, Hu J, et al
    Dynamics of immune responses to inactivated COVID-19 vaccination over 8 months in China.
    J Infect. 2022 Sep 2. pii: S0163-4453(22)00521.
    >> Share

  11. DIMEGLIO C, Tremeaux P, Herin F, Da-Silva I, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population.
    J Infect. 2022 Sep 2. pii: S0163-4453(22)00522.
    >> Share

  12. PATAPNYAN E, Ronen O
    Parallel reduction in the prevalence of Bell's palsy, idiopathic sudden sensorineural hearing loss and viral infection diseases during the COVID-19 pandemic.
    J Infect. 2022 Sep 2. pii: S0163-4453(22)00518.
    >> Share

  13. COOPER DJ, Lear S, Watson L, Shaw A, et al
    A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital.
    J Infect. 2022 Sep 1. pii: S0163-4453(22)00514.
    >> Share

  14. YIN Y, Lin J, Yuan S, Tong S, et al
    The relationship between early isolation and the duration of viral shedding of mild and asymptomatic infection with SARS-CoV-2 Omicron BA.2 variant.
    J Infect. 2022 Sep 1. pii: S0163-4453(22)00520.
    >> Share

    August 2022
  15. LAI CK, Lui GC, Wei Y, Chong KC, et al
    Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitis.
    J Infect. 2022 Aug 31. pii: S0163-4453(22)00513.
    >> Share

  16. LINA L, Zhendong G, Sevalie S, Fangfang Z, et al
    Comparison of the amount of SARS-CoV-2 exhaled by Delta and Omicron patients.
    J Infect. 2022 Aug 28. pii: S0163-4453(22)00512.
    >> Share

  17. KIM SH, Kyu Cho H, Jeon CH, Sung Ock H, et al
    Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia.
    J Infect. 2022 Aug 27. pii: S0163-4453(22)00477.
    >> Share

  18. WANG Y, Zheng J, Zhu K, Wang B, et al
    The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00506.
    >> Share

  19. GIDARI A, Schiaroli E, Sabbatini S, Bastianelli S, et al
    Impact of SARS-CoV-2 Omicron Variants on Serum Neutralization in a Cohort of Healthcare Workers Vaccinated with BNT162b2.
    J Infect. 2022 Aug 25. pii: S0163-4453(22)00507.
    >> Share

  20. BAYHAN GI, Korkmaz IO, Seyda E, Tekeli N, et al
    Are SARS-CoV-2 viral loads in children lower than in adults?
    J Infect. 2022 Aug 24. pii: S0163-4453(22)00509.
    >> Share

  21. LI K, Ruan F, Zhao Z, Guo Z, et al
    Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China.
    J Infect. 2022 Aug 22. pii: S0163-4453(22)00502.
    >> Share

  22. SUN YK, Xing JB, Xu ZY, Gao H, et al
    Re-emergence of Severe Acute Diarrhea Syndrome Coronavirus (SADS-CoV) in Guangxi, China, 2021.
    J Infect. 2022 Aug 21. pii: S0163-4453(22)00504.
    >> Share

  23. MIZOUE T, Yamamoto S, Konishi M, Oshiro Y, et al
    Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00480.
    >> Share

  24. WANG Y, Chen X, Xiao W, Zhao D, et al
    Rapid COVID-19 rebound in a severe COVID-9 patient during 20-day course of Paxlovid.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00478.
    >> Share

  25. NOLASCO S, Vitale F, Geremia A, Tramuto F, et al
    First case of monkeypox virus, SARS-CoV-2 and HIV co-infection.
    J Infect. 2022 Aug 19. pii: S0163-4453(22)00479.
    >> Share

  26. WAN EYF, Mok AHY, Yan VKC, Wang B, et al
    Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.
    J Infect. 2022 Aug 16. pii: S0163-4453(22)00472.
    >> Share

  27. GOMEZ-CARBALLA A, Martinon-Torres F, Salas A
    Is SARS-CoV-2 an oncogenic virus?
    J Infect. 2022 Aug 9. pii: S0163-4453(22)00469.
    >> Share

  28. CHANG YC, Hsiao CT, Chen WL, Su YD, et al
    BioFire FilmArray Respiratory Panel RP2.1 for SARS-CoV-2 detection: The pitfalls.
    J Infect. 2022 Aug 8. pii: S0163-4453(22)00468.
    >> Share

  29. AIELLO TF, Puerta-Alcalde P, Chumbita M, Monzo P, et al
    Infection with the Omicron variant of SARS-CoV-2 is associated with less severe disease in hospitalized patients with COVID-19.
    J Infect. 2022 Aug 5. pii: S0163-4453(22)00461.
    >> Share

  30. WU Y, Ma Z, Zhang Y, Zhang M, et al
    The role of cyclophilins in viral infec and the immune response.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00464.
    >> Share

  31. BASSETTI M, Zuccaro V, Asperges E, Scudeller L, et al
    Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, nonneutropenic, adult patients: an update including COVID-19 data.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00465.
    >> Share

  32. AO Y, Li J, Wei Z, Wang Z, et al
    Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, China.
    J Infect. 2022 Aug 4. pii: S0163-4453(22)00462.
    >> Share

    July 2022
  33. NOH JY, Cheong HJ, Kim WJ, Choi JY, et al
    Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination: Running title: Optimal vaccination interval and ceiling effect.
    J Infect. 2022 Jul 31. pii: S0163-4453(22)00456.
    >> Share

  34. BOJKOVA D, Stack R, Rothenburger T, Kandler JD, et al
    Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.
    J Infect. 2022 Jul 30. pii: S0163-4453(22)00455.
    >> Share

  35. MURPHY SL, Halvorsen B, Barratt-Due A, Am DR, et al
    Remdesivir modifies interferon response in hospitalized COVID-19 patients.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00450.
    >> Share

  36. DZINAMARIRA T, Moyo E, Moyo P, Pierre G, et al
    Childhood immunization services accessibility and utilization during the COVID-19 pandemic in Africa.
    J Infect. 2022 Jul 29. pii: S0163-4453(22)00445.
    >> Share

  37. PASCARELLA S, Ciccozzi M, Benvenuto D, Borsetti A, et al
    Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages.
    J Infect. 2022 Jul 28. pii: S0163-4453(22)00426.
    >> Share

  38. LINA L, Fangfang Z, Sevalie S, Dawei Z, et al
    Characteristics of SARS-CoV-2 exhaled by COVID-19 patients.
    J Infect. 2022 Jul 28. pii: S0163-4453(22)00424.
    >> Share

  39. FU J, Luo Y, Fang X, Lu J, et al
    Genetic variation of Golgi membrane protein 1 is associated with COVID-19 disease.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00420.
    >> Share

  40. VELLAS C, Kamar N, Izopet J
    Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00422.
    >> Share

  41. LI M, Luo Q, Gong C, Li AH, et al
    Prospective Surveillance of Human Adenovirus in Acute Respiratory Infections Reveals Epidemiological Features and the Disappearance of Species B During the COVID-19 Pandemic in Beijing, China.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00423.
    >> Share

  42. HUANG L
    Adjusted control rate closely associated with the epidemiologic evolution of the recent COVID-19 wave in Shanghai, with 94.3% of all new cases being asymptomatic on first diagnosis.
    J Infect. 2022 Jul 14. pii: S0163-4453(22)00418.
    >> Share

  43. HAGIYA H, Hikita T, Habu T, Asada M, et al
    Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people.
    J Infect. 2022 Jul 11. pii: S0163-4453(22)00413.
    >> Share

  44. KHANNA R, Htun HL, Lianjie AL, Kyaw WM, et al
    Staff and patient surveillance in hospitals: good sentinels for the emergence of new SARS-CoV-2 variants.
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00411.
    >> Share

  45. VERA-LISE I, Dominik E, Elisabeth R, Kerstin H, et al
    "Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants".
    J Infect. 2022 Jul 7. pii: S0163-4453(22)00412.
    >> Share

  46. LI M, Yu T
    Statistical concern on evaluating the consistency between gargle samples and nasopharyngeal (NP) swabs in RT-qPCR-based mass screening approach for the diagnosis of COVID-19.
    J Infect. 2022 Jul 6. pii: S0163-4453(22)00408.
    >> Share

  47. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00406.
    >> Share

  48. YAN Y, Davgadorj C, Lyu C, Zhang S, et al
    Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: a cross-sectional study.
    J Infect. 2022 Jul 5. pii: S0163-4453(22)00407.
    >> Share

  49. GAO X, Zhang S, Gou J, Wen Y, et al
    Spike-mediated ACE2 down-regulation involved in the pathogenesis of SARS-CoV-2 infection.
    J Infect. 2022 Jul 3. pii: S0163-4453(22)00404.
    >> Share

  50. YUAN W, Hou Y, Lin Q, Chen L, et al
    How China responds to Omicron.
    J Infect. 2022;85:90-122.
    >> Share

  51. YANG M, Li A, Wang Y, Tran C, et al
    Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: a meta-analysis.
    J Infect. 2022 Jul 1. pii: S0163-4453(22)00384.
    >> Share

    June 2022
  52. CARBONELL R, Urgeles S, Salgado M, Rodriguez A, et al
    NEGATIVE PREDICTIVE VALUE OF PROCALCITONIN TO RULE OUT BACTERIAL RESPIRATORY CO-INFECTION IN CRITICAL COVID-19 PATIENTS.
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00380.
    >> Share

  53. SACERDOTE C, Milani L, Castiglione A, Pagano E, et al
    Risk of Intensive Care Unit admission or mortality in patients hospitalised for COVID-19 during the first two waves: an Italian cohort study.
    J Infect. 2022 Jun 30. pii: S0163-4453(22)00379.
    >> Share

  54. O'MORAIN N, Stack R, Doherty J, Tosetto M, et al
    Research Letter: Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00372.
    >> Share

  55. REN Y, Liu Y, Zhang Z, Liu Y, et al
    SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19.
    J Infect. 2022 Jun 26. pii: S0163-4453(22)00377.
    >> Share

  56. FOURGEAUD J, Toubiana J, Chappuy H, Delacourt C, et al
    No durable impact of COVID-19 measures on the hospital burden of Respiratory Syncytial Virus (France, 2018-2022).
    J Infect. 2022 Jun 24. pii: S0163-4453(22)00375.
    >> Share

  57. YIN Y, Li X, Qian C, Cheng B, et al
    Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study.
    J Infect. 2022 Jun 24. pii: S0163-4453(22)00374.
    >> Share

  58. YANG M, Li A, Jiang L, Wang Y, et al
    Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00369.
    >> Share

  59. NIYOMNAITHAM S, Toh ZQ, Licciardi PV, Wongprompitak P, et al
    Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00370.
    >> Share

  60. RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al
    Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.
    >> Share

  61. PENG H, Wu X, Xiong S, Li C, et al
    Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization analysis.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.
    >> Share

  62. HATCHER J, Gil E, Storey N, Brown JR, et al
    Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.
    >> Share

  63. COCHINO AV, Farkas OM, Ioan A
    Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.
    >> Share

  64. COULSON JM, Adams A, Gray LA, Evans A, et al
    COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00363.
    >> Share

  65. LAZARUS R, Taucher C, Brown C, Corbic I, et al
    Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
    >> Share

  66. WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
    Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
    >> Share

  67. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection.
    J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
    >> Share

  68. GABBI C, Renieri A, Strandvik B
    Geographical distribution of cystic fibrosis carriers as population genetic determinant of COVID-19 spread and fatality in 37 countries.
    J Infect. 2022 Jun 11. pii: S0163-4453(22)00359.
    >> Share

  69. SANG L, Cheng B, Yu Y, Xi Y, et al
    The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00354.
    >> Share

  70. XU QY, Li QL, Jia ZJ, Wu MJ, et al
    Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study.
    J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
    >> Share

  71. LV P, Hu B, Hua R, Zhang J, et al
    A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00350.
    >> Share

  72. IJAZ S, Dicks S, Jegatheesan K, Parker E, et al
    Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients.
    J Infect. 2022 Jun 3. pii: S0163-4453(22)00339.
    >> Share

  73. ABDI B, Ndoadoumgue AL, Djebara S, Zafilaza K, et al
    High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00346.
    >> Share

  74. MELLON G, Rouquette A, Fac C, Carton B, et al
    SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study.
    J Infect. 2022 Jun 2. pii: S0163-4453(22)00345.
    >> Share

  75. GUO Z, Zhao S, Ryu S, Mok CKP, et al
    Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00344.
    >> Share

  76. ZHANG Y, Li J, Jiang L, Chen Q, et al
    Comparison of SARS-CoV-2 aerosol emission from patients with Omicron BA.1 or BA.2 subvariant infection.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00342.
    >> Share

  77. STANKUNAS M, Dziugys A, Skarbalius G, Misiulis E, et al
    EVALUATING THE POTENTIAL IMPACT OF COVID-19 PASSPORTS IN LITHUANIA.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00340.
    >> Share

  78. LI Y, Guo Y, Duan Y
    Changes in Streptococcus pneumoniae infection in children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Infect. 2022 Jun 1. pii: S0163-4453(22)00348.
    >> Share

    May 2022
  79. WANG B, Fu J, Lu A, Yang J, et al
    Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer.
    J Infect. 2022 May 31. pii: S0163-4453(22)00337.
    >> Share

  80. GIANNONE D, Vecchione MB, Czernikier A, Polo ML, et al
    SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV.
    J Infect. 2022 May 27. pii: S0163-4453(22)00315.
    >> Share

  81. KAMALI Z, Vonk JM, Thio CHL, Vaez A, et al
    A Mendelian randomization cytokine screen reveals IL-13 as causal factor in risk of severe COVID-19.
    J Infect. 2022 May 23. pii: S0163-4453(22)00313.
    >> Share

  82. SA R, Isidro J, Borges V, Duarte S, et al
    Unravelling the hurdles of a large COVID-19 epidemiological investigation by viral genomics.
    J Infect. 2022 May 21. pii: S0163-4453(22)00302.
    >> Share

  83. SOVIK S, Barrat-Due A, Kasine T, Olasveengen T, et al
    Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation.
    J Infect. 2022 May 20. pii: S0163-4453(22)00305.
    >> Share

  84. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Immune responses to COVID-19 vaccine BNT162b2 in workers at a research institute in Japan: 6-month follow-up survey.
    J Infect. 2022 May 20. pii: S0163-4453(22)00307.
    >> Share

  85. LIU L, Fan X, Guan Q, Yu C, et al
    Bioavailable testosterone level is associated with COVID-19 severity in female: A sex-stratified Mendelian randomization study.
    J Infect. 2022 May 13. pii: S0163-4453(22)00287.
    >> Share

  86. WU X, Peng H, Xiong S, Li C, et al
    Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer: COVID-19 infection, severity and risk of endometrial cancer.
    J Infect. 2022 May 10. pii: S0163-4453(22)00261.
    >> Share

  87. VAN GRONINGEN KM, Dao BL, Gounder P
    Declines in invasive pneumococcal disease (IPD) during the COVID-19 pandemic in Los Angeles county.
    J Infect. 2022 May 9. pii: S0163-4453(22)00259.
    >> Share

  88. ZHANG YM, Liu XZ, Lin MM, Zan JC, et al
    Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients.
    J Infect. 2022 May 9. pii: S0163-4453(22)00260.
    >> Share

  89. LUCIJANIC M, Cikara T, Bistrovic P, Papic I, et al
    Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.
    J Infect. 2022 May 2. pii: S0163-4453(22)00251.
    >> Share

  90. WAN Z, Lu R, Zhao Y, Zhang C, et al
    Diagnostic strategy of SARS-CoV-2 for containment under China's zero-COVID-19 policy.
    J Infect. 2022 May 1. pii: S0163-4453(22)00250.
    >> Share

  91. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Cancela-Cilleruelo I, Moro-Lopez-Menchero P, et al
    Exploring the recovery curves for long-term post-COVID functional limitations on daily living activities: The LONG-COVID-EXP-CM multicenter study.
    J Infect. 2022;84:722-746.
    >> Share

  92. MARIANI C, Borgonovo F, Capetti AF, Oreni L, et al
    Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
    J Infect. 2022;84:722-746.
    >> Share

    April 2022
  93. HIROTSU Y, Maejima M, Shibusawa M, Natori Y, et al
    SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: genomic surveillance in Japan from September 2021 to March 2022.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00247.
    >> Share

  94. GIANNITRAPANI L, Augello G, Mirarchi L, Amodeo S, et al
    Outcome predictors in SARS-CoV-2 disease (COVID-19): the prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00245.
    >> Share

  95. JIMENEZ D, Martinez-Sanz J, Sainz T, Calvo C, et al
    Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00248.
    >> Share

  96. LI A, Zhang L
    Reduced incidence of acute pharyngitis and increased incidence of chornic pharyngitis under COVID-19 control strategy in Beijing.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00249.
    >> Share

  97. RANA MS, Usman MM, Ikram A, Salman M, et al
    The negative impact of the COVID-19 Pandemic on immunization and the positive impact on Polio eradication in Pakistan and Afghanistan. A dismal scenario.
    J Infect. 2022 Apr 28. pii: S0163-4453(22)00246.
    >> Share

  98. YUAN S, Jiang SC, Zhang ZW, Fu YF, et al
    Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00215.
    >> Share

  99. NGUYEN NN, Houhamdi L, Hoang VT, Stoupan D, et al
    High rate of reinfection with the SARS-CoV-2 Omicron variant.
    J Infect. 2022 Apr 23. pii: S0163-4453(22)00216.
    >> Share

  100. HE L, Zeng C, Xu W, Li Y, et al
    Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00214.
    >> Share

  101. AO G, Li A, Wang Y, Tran C, et al
    Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00210.
    >> Share

  102. CIUFFREDA L, Alcoba-Florez J, Lorenzo-Salazar JM, Gil-Campesino H, et al
    Association of the Delta SARS-CoV-2 variant with 28-day hospital mortality between December 2020 and September 2021.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00212.
    >> Share

  103. LI Y, Wei L, He L, Sun J, et al
    Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00208.
    >> Share

  104. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Reduced neutralizing antibody response in naive Covishield vaccinees against Omicron emphasizes booster vaccination.
    J Infect. 2022 Apr 21. pii: S0163-4453(22)00213.
    >> Share

  105. PANDIT P, Bhatt P, Sahay RR, Joshi Y, et al
    A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00205.
    >> Share

  106. CAI J, Hu S, Lin Q, Ren T, et al
    China's 'dynamic zero COVID-19 strategy' will face greater challenges in the future.
    J Infect. 2022 Apr 18. pii: S0163-4453(22)00209.
    >> Share

  107. DAVIES J, Gibani MM, Portone G, McGregor A, et al
    Cohorting inpatients with Omicron and Delta variants of Sars-CoV-2 does not increase rates of mixed infection.
    J Infect. 2022 Apr 12. pii: S0163-4453(22)00202.
    >> Share

  108. REN Y, Lv L, Li P, Zhang L, et al
    Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction.
    J Infect. 2022 Apr 11. pii: S0163-4453(22)00201.
    >> Share

  109. ZSIGMOND B, Breathnach AS, Mensah A, Ladhani SN, et al
    Very low rates of severe COVID-19 in children hospitalised with confirmed SARS-CoV-2 infection in London, England".
    J Infect. 2022 Apr 10. pii: S0163-4453(22)00203.
    >> Share

  110. WHITAKER H, Tsang RS, Button E, Andrews N, et al
    Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00198.
    >> Share

  111. LIU X, Munro APS, Feng S, Janani L, et al
    Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00200.
    >> Share

  112. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Serum C reactive protein predicts humoral response after BNT162b2 booster administration.
    J Infect. 2022 Apr 8. pii: S0163-4453(22)00197.
    >> Share

  113. YADAV PD, Sahay RR, Agrawal S, Shete A, et al
    Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00193.
    >> Share

  114. MARTIN-BLONDEL G, Marcelin AG, Soulie C, Kaisaridi S, et al
    Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S CoCoPrev study).
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00196.
    >> Share

  115. LIU Y, Li P, Yang L, Li P, et al
    High vaccination coverage slows down genetic diversity of SARS-CoV-2.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00191.
    >> Share

  116. BADDAL B, Bostanci A
    The impact of COVID-19 on the molecular epidemiology of seasonal viral respiratory infections, Cyprus.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00192.
    >> Share

  117. CHENG CY, Hsiao SH, Fang TC, Lin YC, et al
    SARS-CoV2 Antibody Response After a Third Dose of Heterologous ChAdOx1 nCoV-19 and Moderna Vaccine in Chronic Dialysis Patients.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00190.
    >> Share

  118. AKBAR S, Pan D, Ehdode A, Islam R, et al
    Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19.
    J Infect. 2022 Apr 7. pii: S0163-4453(22)00195.
    >> Share

  119. ONG JY, Wang CH, Ms YT, Chen FL, et al
    Nosocomial septicemia in COVID-19 Nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica Septicemia in a Patient of COVID-19.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00188.
    >> Share

  120. SONG W, Yang Y, Huang Y, Chen L, et al
    Acute respiratory infections in children, before and after the COVID-19 pandemic, a sentinel study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00183.
    >> Share

  121. GAGNAIRE J, Bonjean P, Verot E, Boulamail B, et al
    SARS-CoV-2 rapid test versus RT-qPCR on noninvasive respiratory self-samples during a city mass testing campaign.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00184.
    >> Share

  122. BAEK YJ, Lee YJ, Kim JI, Lee S, et al
    Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: a retrospective cohort study.
    J Infect. 2022 Apr 5. pii: S0163-4453(22)00186.
    >> Share

  123. DUVERGER C, Monteil C, Souyri V, Md SF, et al
    Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic.
    J Infect. 2022 Apr 1. pii: S0163-4453(22)00179.
    >> Share

    March 2022
  124. YOON JG, Yoo JS, Lee J, Hyun HJ, et al
    Viable SARS-CoV-2 Shedding Under Remdesivir and Dexamethasone Treatment.
    J Infect. 2022 Mar 26. pii: S0163-4453(22)00177.
    >> Share

  125. MENG J, Ge Q, Li J, Lu X, et al
    Protective trend of anti-androgen therapy during the COVID-19 pandemic: a meta-analysis.
    J Infect. 2022 Mar 24. pii: S0163-4453(22)00175.
    >> Share

  126. SCHILDGEN V, Lusebrink J, Schildgen O
    Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnarable individuals.
    J Infect. 2022 Mar 23. pii: S0163-4453(22)00173.
    >> Share

  127. YADAV PD, Sapkal GN, Sahay RR, Patil DY, et al
    Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naive vaccinees.
    J Infect. 2022 Mar 19. pii: S0163-4453(22)00170.
    >> Share

  128. YANG G, Ren Z, Zou Y, Xu Q, et al
    Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: lessons from the "dynamic zero-COVID policy" in mainland China.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00141.
    >> Share

  129. MURGIA F, Fiamma M, Serra S, Olla S, et al
    The impact of secondary infections in COVID-19 critically ill patients.
    J Infect. 2022 Mar 18. pii: S0163-4453(22)00171.
    >> Share

  130. DIMEGLIO C, Loubes JM, Migueres M, Saune K, et al
    Influence of vaccination and prior immunity on the dynamics of Omicron BA.1 and BA.2 sub-variants.
    J Infect. 2022 Mar 17. pii: S0163-4453(22)00140.
    >> Share

  131. RYAN P, Perez-Garcia F, Torres-Macho J, Bibiano C, et al
    Misdiagnosis rate of among negative COVID-19 patients in real-life with Panbio COVID-19 Antigen Rapid Test during 2021.
    J Infect. 2022 Mar 16. pii: S0163-4453(22)00139.
    >> Share

  132. AO G, Wang Y, Li A, Tran C, et al
    The effect of canakinumab on clinical outcomes in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Mar 14. pii: S0163-4453(22)00137.
    >> Share

  133. CHEN C, Tang J, Wang C, Wen W, et al
    Meta-Analysis of Post-traumatic Stress Disorder and COVID-19 in Patients Discharged.
    J Infect. 2022 Mar 10. pii: S0163-4453(22)00134.
    >> Share

  134. XIANG B, Yang L, Ye Z, Ren T, et al
    Vaccination of Susceptible Animals Against SARS-CoV-2.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00131.
    >> Share

  135. FERRE VM, Lebourgeois S, Chenane HR, Menidjel R, et al
    Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00126.
    >> Share

  136. BONNET B, Chabrolles H, Archimbaud C, Brebion A, et al
    Comparative T and B immune responses of four different anti-COVID-19 vaccine strategies 6 months after vaccination.
    J Infect. 2022 Mar 9. pii: S0163-4453(22)00132.
    >> Share

  137. FANTINI J, Devaux CA, Yahi N, Frutos R, et al
    The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans.
    J Infect. 2022 Mar 6. pii: S0163-4453(22)00129.
    >> Share

  138. AU WY, Ye C, Briner SL, Suarez GD, et al
    Systematic comparison between BNT162b2 and CoronaVac in the seroprotection against SARS-CoV-2 Alpha, Beta, Gamma, and Delta variants.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00123.
    >> Share

  139. GIMENEZ E, Albert E, Burgos JS, Peiro S, et al
    SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00124.
    >> Share

  140. BONGIOVANNI M, Spada E, De Angelis C, Liuzzi G, et al
    SARS-CoV-2: about reinfection, vaccination and neutralizing antibodies.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00125.
    >> Share

  141. SYED MA DR, A/Qotba HA Dr, Al Nuaimi AS Dr
    Effectiveness of COVID-19 vaccines in Qatar.
    J Infect. 2022 Mar 1. pii: S0163-4453(22)00121.
    >> Share

  142. HAO M, Zhu Y, Fan S, Wu X, et al
    Detection of human respiratory viruses among hospitalized children aged
    J Infect. 2022;84:418-467.
    >> Share

    February 2022
  143. PUTRI DU, Lin CF, Hung CS, Huang CK, et al
    Distinct B and NKT cell Responses Shape the Delayed Response to ChAdOx1 nCoV-19 Vaccine in End-Stage Renal Disease.
    J Infect. 2022 Feb 28. pii: S0163-4453(22)00116.
    >> Share

  144. HAYASHI JY, Simizo A, Miyamoto JG, Costa LVS, et al
    Humoral and Cellular Responses to Vaccination with Homologous CoronaVac or ChAdOx1 and Heterologous Third Dose with BNT162b2.
    J Infect. 2022 Feb 27. pii: S0163-4453(22)00115.
    >> Share

  145. KONIG S, Hohenstein S, Leiner J, Hindricks G, et al
    National mortality data for Germany before and throughout the pandemic: there is an excess mortality exceeding COVID-19-attributed fatalities.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00113.
    >> Share

  146. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load.
    J Infect. 2022 Feb 26. pii: S0163-4453(22)00114.
    >> Share

  147. PASCARELLA S, Ciccozzi M, Bianchi M, Benvenuto D, et al
    The value of electrostatic potentials of the Spike Receptor binding and N-terminal domains in addressing transmissibility and infectivity of SARS-CoV-2 Variants. of Concern.
    J Infect. 2022 Feb 23. pii: S0163-4453(22)00112.
    >> Share

  148. DE MICHELENA P, Torres I, Ramos-Garcia A, Gozalbes V, et al
    Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.
    J Infect. 2022 Feb 22. pii: S0163-4453(22)00110.
    >> Share

  149. SAHAY RR, Patil DY, Sapkal GN, Deshpande GR, et al
    SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00082.
    >> Share

  150. TANG K, Wu X, Luo Y, Wei Z, et al
    Meta-analysis of Immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients.
    J Infect. 2022 Feb 19. pii: S0163-4453(22)00081.
    >> Share

  151. SAEED A, Ahmad B, Majaz S, Nouroz F, et al
    Targeting Omicron and other reported SARS-CoV-2 lineages by Potent inhibitors of Main Protease 3CL Mpro: Molecular Simulation Analysis.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00079.
    >> Share

  152. KWOK KO, Wei WI, Ma BHM, Ip M, et al
    Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00078.
    >> Share

  153. LIPPI G, Nocini R, Henry BM
    Is SARS-CoV-2 Omicron (B.1.1.529) variant causing different symptoms?
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00077.
    >> Share

  154. ZHENG J, Wang Z, Li J, Zhang Y, et al
    High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00075.
    >> Share

  155. FERRI S, Polidoro A, Ciacciarelli M, Ceratti U, et al
    Decline of immune humoral response after BNT162b2 Vaccine.
    J Infect. 2022 Feb 17. pii: S0163-4453(22)00076.
    >> Share

  156. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Assessment 2 months after the administration of a 3rd dose mRNA: A new variant-adapted vaccine is expected.
    J Infect. 2022 Feb 15. pii: S0163-4453(22)00073.
    >> Share

  157. BLANCO I, Violan C, Suner C, Garcia-Prieto J, et al
    Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2022 Feb 13. pii: S0163-4453(22)00072.
    >> Share

  158. YADAV PD, Sapkal GN, Sahay RR, Potdar VA, et al
    Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns.
    J Infect. 2022 Feb 11. pii: S0163-4453(22)00070.
    >> Share

  159. RIGHI E, Mirandola M, Mazzaferri F, Dossi G, et al
    Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study.
    J Infect. 2022 Feb 9. pii: S0163-4453(22)00065.
    >> Share

  160. MIGUERES M, Dimeglio C, Tremeaux P, Abravanel F, et al
    Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variant.
    J Infect. 2022 Feb 7. pii: S0163-4453(22)00054.
    >> Share

  161. ZHOU W, Zhong L, Tang X, Huang T, et al
    The early warning and monitoring of COVID-19 by using Baidu Search Index in China.
    J Infect. 2022 Feb 6. pii: S0163-4453(22)00063.
    >> Share

  162. LAZOR-BLANCHET C, Zygoura P, Dafni U, Lamoth F, et al
    Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
    J Infect. 2022 Feb 5. pii: S0163-4453(22)00062.
    >> Share

  163. WESTROP SJ, Whitaker HJ, Powell AA, Power L, et al
    Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England.
    J Infect. 2022 Feb 4. pii: S0163-4453(22)00055.
    >> Share

  164. CUI H, Liu J, Zhang L
    The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00057.
    >> Share

  165. DIMEGLIO C, Migueres M, Mansuy JM, Saivin S, et al
    Antibody titers and breakthrough infections with Omicron SARS-CoV-2.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00060.
    >> Share

  166. KIVIT C, Groen K, Jongbloed M, Linssen C, et al
    An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown.
    J Infect. 2022 Feb 3. pii: S0163-4453(22)00058.
    >> Share

  167. ESTOFOLETE CF, Fares GF, Banho CA, Sacchetto L, et al
    Predictors of death in COVID-19 vaccine breakthrough infections in Brazil.
    J Infect. 2022 Feb 2. pii: S0163-4453(22)00059.
    >> Share

  168. LI Z, Tao B, Hu Z, Yi Y, et al
    Effects of short-term ambient particulate matter exposure on the risk of severe COVID-19.
    J Infect. 2022 Feb 1. pii: S0163-4453(22)00052.
    >> Share

    January 2022
  169. XU W, Tang J, Chen C, Wang C, et al
    Safety and Efficacy of the Covid-19 Vaccine in children andor adolescents: A meta-analysis.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00050.
    >> Share

  170. MATTIUZZI C, Lippi G
    COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00051.
    >> Share

  171. LIVINGSTONE R, Lin H, Brendish NJ, Poole S, et al
    Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.
    J Infect. 2022 Jan 30. pii: S0163-4453(22)00049.
    >> Share

  172. JI G, Chen C, Zhou M, Wen W, et al
    Post-COVID-19 Fatigue among COVID-19 in patients discharged from hospital: A meta-analysis.
    J Infect. 2022 Jan 28. pii: S0163-4453(22)00031.
    >> Share

  173. MENSAH AA, Lacy J, Stowe J, Seghezzo G, et al
    Evaluation of disease severity during SARS-COV-2 reinfection, January 2020 to April 2021, England: an observational study.
    J Infect. 2022 Jan 24. pii: S0163-4453(22)00010.
    >> Share

  174. RANA MS, Usman MM, Alam MM, Ikram A, et al
    Impact of previous SARS-CoV-2 infection on the rate of mortality in dengue. A preliminary report from Pakistan.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00027.
    >> Share

  175. SCHEPERS M, Zanger P, Jahn K, Konig J, et al
    Multi-household social gatherings contribute to the second SARS-CoV-2 wave in Rhineland-Palatinate.
    J Infect. 2022 Jan 23. pii: S0163-4453(22)00028.
    >> Share

  176. GAO R, Xu Y, Zhu G, Zhou S, et al
    Genetic variation associated with COVID-19 is also associated with endometrial cancer.
    J Infect. 2022 Jan 22. pii: S0163-4453(22)00026.
    >> Share

  177. FAVRESSE J, Bayart JL, David C, Dogne JM, et al
    Nucleocapsid Serum Antigen Determination in SARS-CoV-2 Infected Patients Using the Single Molecule Array Technology and Prediction of Disease Severity.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00022.
    >> Share

  178. DUCLOUX D, Bamoulid J, Chabannes M, Colladant M, et al
    Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00020.
    >> Share

  179. MAO Q, Wang C, Zhou M, Wen W, et al
    A meta-analysis of the association between calprotectin and the severity of COVID-19.
    J Infect. 2022 Jan 21. pii: S0163-4453(22)00023.
    >> Share

  180. ELFIKY AA, Ibrahim IM
    Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view.
    J Infect. 2022 Jan 18. pii: S0163-4453(22)00015.
    >> Share

  181. ZHANG Y, Jiang N, Qi W, Li T, et al
    Intra-host SARS-CoV-2 Single-Nucleotide Variants Emerged During the Early Stage of COVID-19 Pandemic Forecast Population Fixing Mutations.
    J Infect. 2022 Jan 15. pii: S0163-4453(22)00017.
    >> Share

  182. XU Y, Gao R, Zhu G, Zhou S, et al
    Genetic variation of allergic disease is associated with the susceptibility to COVID-19.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00016.
    >> Share

  183. PILECKY M, Harm S, Bauer C, Zottl J, et al
    Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR.
    J Infect. 2022 Jan 14. pii: S0163-4453(22)00011.
    >> Share

  184. THANH TT, Nhan NTT, Anh NT, Chung LT, et al
    SARS-CoV-2 RNA loads in Vietnamese children.
    J Infect. 2022 Jan 13. pii: S0163-4453(22)00012.
    >> Share

  185. LIN M, Chen H, Wang Y, Qiu S, et al
    A Model Study on Predicting New COVID-19 Cases in China Based on Social and News Media.
    J Infect. 2022 Jan 9. pii: S0163-4453(22)00009.
    >> Share

  186. CHEN JM, Chen YQ, Sun YX
    Control of COVID-19 in China likely reduced the burden of multiple other infectious diseases.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00001.
    >> Share

  187. HAN X, Xu P, Wang H, Mao J, et al
    Incident changes in the prevalence of respiratory virus among children during COVID-19 pandemic in Hangzhou, China.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00006.
    >> Share

  188. FAUSTINI S, Shields A, Banham G, Wall N, et al
    Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00002.
    >> Share

  189. DE MICHELENA P, Torres I, Albert E, Bracho A, et al
    Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.
    J Infect. 2022 Jan 8. pii: S0163-4453(22)00007.
    >> Share

  190. BORMAN AM, Fountain H, Guy R, Casale E, et al
    Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England.
    J Infect. 2022 Jan 4. pii: S0163-4453(21)00665.
    >> Share

  191. WHITAKER HJ, Tsang RS, Byford R, Andrews NJ, et al
    Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups.
    J Infect. 2022 Jan 3. pii: S0163-4453(21)00664.
    >> Share

  192. XU B, Ma FQ, He C, Wu ZQ, et al
    Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
    J Infect. 2022 Jan 2. pii: S0163-4453(21)00659.
    >> Share

  193. MARRAMS ARM, Kobayashi T, Suzuki H, Alsuhaibani M, et al
    Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis.
    J Infect. 2022 Jan 1. pii: S0163-4453(21)00658.
    >> Share

    December 2021
  194. SIMIONATTO VZ, Evaristo M, Santos EV, Mello R, et al
    SARS-CoV-2 SEROLOGICAL CROSS-REACTIVITY TESTING IN BRAZILIAN BLOOD DONORS, OCTOBER-DECEMBER, 2019.
    J Infect. 2021 Dec 31. pii: S0163-4453(21)00660.
    >> Share

  195. FINCH LS, Harris A, Lester C, Veal D, et al
    Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00657.
    >> Share

  196. KAWAHARA T, Ueki Y, Nawa N, Miyamae S, et al
    Who is a super-spreader? Determinants of people with higher PCR copy number of SARS-CoV-2 during Mar 2020 to June 2021 in Japan.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00656.
    >> Share

  197. ARORA U, Priyadarshi M, Katiyar V, Soneja M, et al
    Novel risk factors for Coronavirus disease-associated mucormycosis(CAM): a case-control study during the outbreak in India.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00654.
    >> Share

  198. ZENG C, Ye Z, Fu L, Ye Y, et al
    Prediction analysis of porcine AXL protein as a potential receptor for SARS-CoV-2.
    J Infect. 2021 Dec 30. pii: S0163-4453(21)00655.
    >> Share

  199. VENTERO MP, Moreno-Perez O, Molina-Pardines C, Paytuvi-Gallart A, et al
    Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00647.
    >> Share

  200. XU B, Ma FQ, He C, Wu ZQ, et al
    Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China.
    J Infect. 2021 Dec 25. pii: S0163-4453(21)00642.
    >> Share

  201. LAI X, Wang J, Duan J, Gong Y, et al
    Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia.
    J Infect. 2021 Dec 23. pii: S0163-4453(21)00640.
    >> Share

  202. RUBESHKUMAR P, John A, Narnaware M, M J, et al
    Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00632.
    >> Share

  203. QIN G, Yang J, Zhao C, Ren J, et al
    The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00634.
    >> Share

  204. VINER R, Waddington C, Mytton O, Booy R, et al
    Transmission of SARS-CoV-2 by children and young people in households and schools: a meta-analysis of population-based and contact-tracing studies.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00633.
    >> Share

  205. SYED-ABDUL S, Babu AS, Bellamkonda RS, Itumalla R, et al
    Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from a public hospital in India.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00639.
    >> Share

  206. GENG Y, Zhang L
    The impact of non-pharmaceutical interventions during COVID-19 pandemic on three children infectious diseases in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00645.
    >> Share

  207. COLTELLA L, Ranno S, Piccioni L, Linardos G, et al
    Quantitative SARS-CoV-2 antigen test as a tool able to predict the stage of the infection.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00636.
    >> Share

  208. KHURRAM M, Ali G, Awan UA, Afzal MS, et al
    COVID-19 and alarming dengue co-epidemics in the dilapidated healthcare system in Pakistan: Where to focus!
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00638.
    >> Share

  209. MAANI AA, Wahaibi AA, Nazer W, Al-Zadjali N, et al
    The utilization of HCWs surveillance as an early warning of COVID-19 epidemic activity in the community.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00629.
    >> Share

  210. GAO P, Zhang X, Zhang S, Yu Y, et al
    COVID-19 persists: Current risk of a recurrence of the epidemic in China.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00643.
    >> Share

  211. COSTA R, Olea B, Bracho MA, Albert E, et al
    RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00641.
    >> Share

  212. ORENES-PINERO E, Navas-Carrillo D, Moreno-Docon A, Ortega-Garcia JA, et al
    Confirmation of SARS-CoV-2 airborne dissemination indoors using "COVID-19 traps".
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00630.
    >> Share

  213. YAN F, Gao F
    Mutant EK1 with Q1004E/N1006I: a promising fusion inhibitor for the HR1 domain of SARS-CoV-2.
    J Infect. 2021 Dec 22. pii: S0163-4453(21)00644.
    >> Share

  214. WANG R
    Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease.
    J Infect. 2021 Dec 21. pii: S0163-4453(21)00631.
    >> Share

  215. MANOLACHE NG, Ursachi V, Scohy A, Desmet C, et al
    Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases.
    J Infect. 2021 Dec 14. pii: S0163-4453(21)00597.
    >> Share

  216. OWEN SI, Williams CT, Garrod G, Fraser AJ, et al
    Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.
    J Infect. 2021 Dec 11. pii: S0163-4453(21)00598.
    >> Share

  217. FANG X, Ming C, Cen Y, Lin H, et al
    Post-sequelae one year after hospital discharge among older COVID-19 patients: a multi-center prospective cohort study.
    J Infect. 2021 Dec 10. pii: S0163-4453(21)00596.
    >> Share

  218. MAK WA, Koeleman JGM, van der Vliet M, Keuren F, et al
    SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study.
    J Infect. 2021 Dec 9. pii: S0163-4453(21)00593.
    >> Share

  219. QUINTAO TSC, Slavov SN, de Oliveira PM, Bezerra RDS, et al
    Viral metagenomics in nasopharyngeal swabs of Brazilian patients negative for SARS-CoV-2 unveils the presence of Chikungunya virus infection.
    J Infect. 2021 Dec 5. pii: S0163-4453(21)00585.
    >> Share

    November 2021
  220. OESER C, Whitaker H, Linley E, Borrow R, et al
    Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the Delta wave and vaccination.
    J Infect. 2021 Nov 30. pii: S0163-4453(21)00584.
    >> Share

  221. HAN X, Xu J, Hou H, Yang H, et al
    Significant association of pre-existing asthma with an increased risk for ICU admission among COVID-19 patients: Evidence based on a meta-analysis.
    J Infect. 2021 Nov 29. pii: S0163-4453(21)00582.
    >> Share

  222. MENTZER DAJ, James T, Yongya M, Cox S, et al
    Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.
    J Infect. 2021 Nov 26. pii: S0163-4453(21)00580.
    >> Share

  223. ALDERSON MR, Arkwright PD, Bai X, Black S, et al
    Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review.
    J Infect. 2021 Nov 24. pii: S0163-4453(21)00578.
    >> Share

  224. BEHNOOD SA, Shafran R, Bennett SD, Zhang A, et al
    Persistent symptoms following SARS-CoV-2 infection among children and young people: a meta-analysis of controlled and uncontrolled studies.
    J Infect. 2021 Nov 20. pii: S0163-4453(21)00555.
    >> Share

  225. LEBOURGEOIS S, Menidjel R, Chenane HR, Ferre VM, et al
    Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00556.
    >> Share

  226. LUO L, Luo T, Du M, Mei H, et al
    Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: a systematic review and meta-analysis.
    J Infect. 2021 Nov 19. pii: S0163-4453(21)00557.
    >> Share

  227. PAN D, Kim JW, Nazareth J, Assadi S, et al
    Quantification and prognostic significance of interferon-gamma secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19.
    J Infect. 2021 Nov 18. pii: S0163-4453(21)00554.
    >> Share

  228. TSAI SC, Chang WW, Lee WS
    Analysis of an outbreak of COVID-19(alpha-variant) with rapid progression to mortality in Taipei, Taiwan.
    J Infect. 2021 Nov 17. pii: S0163-4453(21)00553.
    >> Share

  229. CHAPPELL H, Patel R, Driessens C, Tarr AW, et al
    Immunocompromised children and young people are at no increased risk of severe COVID-19.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00548.
    >> Share

  230. YAN X, Zhu S, Jin Z, Chen G, et al
    Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients.
    J Infect. 2021 Nov 13. pii: S0163-4453(21)00550.
    >> Share

  231. BEN S, Xin J, Chen S, Jiang Y, et al
    Global internet search trends related to gastrointestinal symptoms predict regional COVID-19 outbreaks.
    J Infect. 2021 Nov 9. pii: S0163-4453(21)00546.
    >> Share

  232. MARTIN-VICENTE M, Berenguer J, Munoz-Gomez MJ, Diez C, et al
    Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19: Anti-SARS-CoV-2 S antibodies in PWH.
    J Infect. 2021 Nov 6. pii: S0163-4453(21)00545.
    >> Share

  233. BURGI JJ, Rosslein M, Hornung H, Jentsch J, et al
    Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time - indication of persistence of the virus?: Indication of persistence of SARS-CoV-2?
    J Infect. 2021 Nov 5. pii: S0163-4453(21)00544.
    >> Share

  234. GIMENEZ E, Alberola J, Torres I, Albert E, et al
    Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty(R) COVID-19 vaccine.
    J Infect. 2021 Nov 2. pii: S0163-4453(21)00542.
    >> Share

  235. HESKIN J, Pallett SJC, Mughal N, Jones R, et al
    Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: a qualitative analysis across two London hospitals.
    J Infect. 2021 Nov 1. pii: S0163-4453(21)00537.
    >> Share

    October 2021
  236. NISHIKIMI A, Watanabe K, Watanabe A, Yasuoka M, et al
    Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00538.
    >> Share

  237. YE Q, Liu H, Shang S
    Non-pharmaceutical interventions reduced the incidence and exacerbation of allergic diseases in children during the COVID-19 pandemic.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00541.
    >> Share

  238. WANG J, Zou H, Corpe C
    An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in China.
    J Infect. 2021 Oct 30. pii: S0163-4453(21)00536.
    >> Share

  239. LUMLEY SF, Richens N, Lees E, Cregan J, et al
    Changes in paediatric respiratory infections at a UK teaching hospital 2016-2021; impact of the SARS-CoV-2 pandemic.
    J Infect. 2021 Oct 29. pii: S0163-4453(21)00540.
    >> Share

  240. LI X, Chen H, Lu L, Chen LL, et al
    High compliance to infection control measures prevented guest-to-staff transmission in COVID-19 quarantine hotels.
    J Infect. 2021 Oct 26. pii: S0163-4453(21)00533.
    >> Share

  241. CHONG Y, Tani N, Goto T, Yonekawa A, et al
    Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00508.
    >> Share

  242. EPAULARD O, Buisson M, Nemoz B, Marechal ML, et al
    Persistence at one year of neutralising antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00507.
    >> Share

  243. BORMAN AM, Fraser M, Patterson Z, McLachlan S, et al
    Fungal biomarker testing turn-around-times at the UK National Mycology Reference Laboratory: setting the record straight.
    J Infect. 2021 Oct 20. pii: S0163-4453(21)00509.
    >> Share

  244. GUPTA A, Bhoyar RC, Mirza S, Jolly B, et al
    SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.
    J Infect. 2021 Oct 19. pii: S0163-4453(21)00506.
    >> Share

  245. AHMAD HA, Khan H, Shahzad M, Haq ZU, et al
    Suspected reinfections of SARS-COV-2 in Khyber Pakhtunkhwa, Pakistan - analysis of province-wide testing database.
    J Infect. 2021 Oct 9. pii: S0163-4453(21)00503.
    >> Share

  246. BOSHIER FAT, Venturini C, Stirrup O, Guerra-Assuncao JA, et al
    The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital study.
    J Infect. 2021 Oct 2. pii: S0163-4453(21)00493.
    >> Share

  247. HUMBERT MV, Opurum PC, Brendish NJ, Poole S, et al
    A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.
    J Infect. 2021 Oct 1. pii: S0163-4453(21)00492.
    >> Share

  248. FERNANDEZ-DE-LAS-PENAS C, Gomez-Mayordomo V, de-la-Llave-Rincon AI, Palacios-Cena M, et al
    Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:496-522.
    >> Share

    September 2021
  249. A A, M F, J CO, Ejm M, et al
    Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study.
    J Infect. 2021 Sep 30. pii: S0163-4453(21)00489.
    >> Share

  250. FERRE VM, Lebourgeois S, Menidjel R, Collin G, et al
    Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00488.
    >> Share

  251. LEMENAND O, Coeffic T, Thibaut S, Colomb-Cotinat M, et al
    Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France.
    J Infect. 2021 Sep 29. pii: S0163-4453(21)00486.
    >> Share

  252. LECOINTRE L, Venkatasamy A, Wehr M, Koch A, et al
    Multicentric evaluation of a 3D-printed simulator for COVID- 19 nasopharyngeal swab collection in testing centers.
    J Infect. 2021 Sep 24. pii: S0163-4453(21)00485.
    >> Share

  253. DIMEGLIO C, Herin F, Martin-Blondel G, Miedouge M, et al
    Antibody titers and protection against a SARS-CoV-2 infection.
    J Infect. 2021 Sep 21. pii: S0163-4453(21)00483.
    >> Share

  254. ALEMANY A, Millat-Martinez P, Ouchi D, Corbacho-Monne M, et al
    Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00481.
    >> Share

  255. MCMILLAN T, Jones C, O'Connor CJ, Nolan D, et al
    Risk factors associated with bloodstream infections among critically ill patients with COVID-19.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00480.
    >> Share

  256. LUNA-MUSCHI A, Borges IC, de Faria E, Barboza AS, et al
    Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers.
    J Infect. 2021 Sep 16. pii: S0163-4453(21)00474.
    >> Share

  257. FANG C, Zhou Z, Li J, Zhou M, et al
    Incident changes of rotavirus enteritis among children during the coronavirus disease-2019 pandemic in Hangzhou, China.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00478.
    >> Share

  258. AWAN UA, Malik MW, Khan MI, Khattak AA, et al
    Predicting COVID-19 incidence in war-torn Afghanistan: A timely response is required!
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00473.
    >> Share

  259. CHEN H, Zhao X, Li L, Yan S, et al
    Mental health and physical symptoms of people quarantined during the COVID-19 outbreak.
    J Infect. 2021 Sep 15. pii: S0163-4453(21)00479.
    >> Share

  260. ZUO L, Ao G, Wang Y, Gao M, et al
    Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis.
    J Infect. 2021 Sep 14. pii: S0163-4453(21)00477.
    >> Share

  261. QIU S, Wang D, Zhang Y, Hu Y, et al
    Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites.
    J Infect. 2021 Sep 13. pii: S0163-4453(21)00471.
    >> Share

  262. OLEARO F, Norz D, Hoffman A, Grunwald M, et al
    Clinical performance and accuracy of a qPCR-based SARS-CoV-2 mass-screening workflow for healthcare-worker surveillance using pooled self-sampled gargling solutions: a cross-sectional study.
    J Infect. 2021 Sep 6. pii: S0163-4453(21)00451.
    >> Share

  263. QIU S, Zhang Y, Wang D, Hu Y, et al
    The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.
    J Infect. 2021 Sep 2. pii: S0163-4453(21)00449.
    >> Share

  264. ALKALAMOUNI H, Hitti E, Zaraket H
    Adopting fresh air ventilation may reduce the risk of airborne transmission of SARS-CoV-2 in COVID-19 unit.
    J Infect. 2021 Sep 1. pii: S0163-4453(21)00450.
    >> Share

  265. CHANDRA S, Rawal R
    The surge in Covid related mucormycosis.
    J Infect. 2021;83:381-412.
    >> Share

    August 2021
  266. SNELL LB, Awan AR, Charalampous T, Alcolea-Medina A, et al
    SARS-CoV-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00445.
    >> Share

  267. STRALIN K, Bruce D, Wahlstrom E, Walther S, et al
    Impact of the Alpha VOC on disease severity in SARS-CoV-2-positive adults in Sweden.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00448.
    >> Share

  268. BHATTACHARYA A, Collin SM, Stimson J, Thelwall S, et al
    Healthcare-associated COVID-19 in England: a national data linkage study.
    J Infect. 2021 Aug 30. pii: S0163-4453(21)00443.
    >> Share

  269. QIU S, Hu Y, Cheng L
    A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease.
    J Infect. 2021 Aug 26. pii: S0163-4453(21)00442.
    >> Share

  270. MORALES-ORTEGA A, Farfan-Sedano AI, Izquierdo-Martinez A, Llarena-Barroso C, et al
    Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00436.
    >> Share

  271. GUIGON A, Faure E, Lemaire C, Chopin MC, et al
    Emergence of Q493R mutation in SARS-CoV-2 spike protein during bamlanivimab/etesevimab treatment and resistance to viral clearance.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00435.
    >> Share

  272. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00433.
    >> Share

  273. QIU S, Hu Y
    Are COVID-19 susceptibility genes related to lung cancer?
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00434.
    >> Share

  274. KRAL S, Banfi C, Niedrist T, Sareban N, et al
    Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.
    J Infect. 2021 Aug 22. pii: S0163-4453(21)00419.
    >> Share

  275. TEYSSOU E, Delagreverie H, Visseaux B, Lambert-Niclot S, et al
    The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00416.
    >> Share

  276. BRAMLEY A, Crocker-Buque T, Breuer J, Mahungu TW, et al
    Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00418.
    >> Share

  277. WANG C, Kang K, Lan X, Fei D, et al
    Cytokinelevels in sputum, not serum, may be more helpful 1 for indicating the damage in the lung and the prognosis of severe COVID-19 - A Case Series.
    J Infect. 2021 Aug 19. pii: S0163-4453(21)00415.
    >> Share

  278. YOU YS, Kim JS
    Influenza and Anosmia: important prediction factors for severity and death of COVID-19.
    J Infect. 2021 Aug 18. pii: S0163-4453(21)00413.
    >> Share

  279. KRETSCHMER A, Kossow A, Grune B, Schildgen O, et al
    False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden.
    J Infect. 2021 Aug 17. pii: S0163-4453(21)00402.
    >> Share

  280. DOUXFILS J, Gillot C, Mullier F, Favresse J, et al
    Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ.
    J Infect. 2021 Aug 15. pii: S0163-4453(21)00405.
    >> Share

  281. LADHANI SN, Ireland G, Baawuah F, Beckmann J, et al
    Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: active prospective surveillance, December 2020 to March 2021, England.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00401.
    >> Share

  282. ARANDA J, Oriol I, Martin M, Feria L, et al
    Long-term impact of COVID-19 associated acute respiratory distress syndrome.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00396.
    >> Share

  283. WEY EQ, Bristow C, Nandani A, O'Farrell B, et al
    Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19.
    J Infect. 2021 Aug 13. pii: S0163-4453(21)00400.
    >> Share

  284. COSTA R, Bueno F, Gimenez E, Bracho A, et al
    Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00398.
    >> Share

  285. FURUSE Y, Tsnchiya N, Miyahara R, Yasuda D, et al
    COVID-19 case-clusters and transmission chains in the communities in Japan.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00399.
    >> Share

  286. DONG M, Luo M, Li A, Xie H, et al
    Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study.
    J Infect. 2021 Aug 11. pii: S0163-4453(21)00395.
    >> Share

  287. ALLEN N, Brady M, Martin AIC, Domegan L, et al
    Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals.
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00394.
    >> Share

  288. KHAN MI, Qureshi H, Khattak AA, Awan UA, et al
    Predicting COVID-19 incidence in Pakistan: It's time to act now!
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00393.
    >> Share

  289. YAHI N, Chahinian H, Fantini J
    Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination ?
    J Infect. 2021 Aug 9. pii: S0163-4453(21)00392.
    >> Share

  290. FERNANDEZ-DE-LAS-PENAS C
    Post-COVID Functional Limitations on Daily Living Activities are Associated with Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection and Internal Care Unit Admission: A Multicenter Study.
    J Infect. 2021 Aug 7. pii: S0163-4453(21)00391.
    >> Share


  291. Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00388.
    >> Share

  292. GOBBI F, Buonfrate D, Silva R, Martini D, et al
    Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose.
    J Infect. 2021 Aug 6. pii: S0163-4453(21)00390.
    >> Share

  293. LAMB G, Heskin J, Randell P, Mughal N, et al
    Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00383.
    >> Share


  294. Predominance of Delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021.
    J Infect. 2021 Aug 5. pii: S0163-4453(21)00387.
    >> Share

  295. TANNER AR, Phan H, Brendish NJ, Borca F, et al
    SARS-CoV-2 Viral load at presentation to hospital is independently associated with the risk of death.
    J Infect. 2021 Aug 4. pii: S0163-4453(21)00384.
    >> Share

  296. MILLER E, Waight PA, Andrews NJ, McOwat K, et al
    Transmission of SARS-CoV-2 in the household setting: a prospective cohort study in children and adults in England.
    J Infect. 2021 Aug 1. pii: S0163-4453(21)00380.
    >> Share

  297. FERNANDEZ-DE-LAS-PENAS C, Palacios-Cena D, Gomez-Mayordomo V, Rodriuez-Jimenez J, et al
    Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study.
    J Infect. 2021;83:237-279.
    >> Share

  298. FERNANDEZ-DE-LAS-PENAS C, Torres-Macho J, Velasco-Arribas M, Arias-Navalon JA, et al
    Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study.
    J Infect. 2021;83:237-279.
    >> Share

    July 2021
  299. LUMLEY SF, Constantinides B, Sanderson N, Rodger G, et al
    Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00377.
    >> Share

  300. BENE MC, Bittencourt MC, Chevallier P
    Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-full glass perspective.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00370.
    >> Share

  301. LIM SY, Kim JY, Lee JA, Kwon JS, et al
    Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without.
    J Infect. 2021 Jul 28. pii: S0163-4453(21)00375.
    >> Share

  302. CIUFFREDA L, Salazar JML, Alcoba-Florez J, Rodriguez-Perez H, et al
    Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00373.
    >> Share

  303. RAJAMANICKAM A, Kumar NP, Padmapriyadarsini C, Nancy A, et al
    Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00372.
    >> Share

  304. RANA MS, Usman M, Salman M, Alam MM, et al
    Potential impact of COVID-19 Pandemic on escalating antimicrobial resistance in Pakistan.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00368.
    >> Share

  305. WHITTAKER R, Kristofferson AB, Seppala E, Salamanca BV, et al
    Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 - April 2021.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00366.
    >> Share

  306. COSENTINO G, Bernard M, Ambroise J, Giannoli JM, et al
    SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community.
    J Infect. 2021 Jul 27. pii: S0163-4453(21)00374.
    >> Share

  307. AWAN UA, Malik MW, Khattak AA, Ahmed H, et al
    Emerging Polio Hotspots in Pakistan: Challenges and the way forward: COVID-19 and re-emergence of Polio in Pakistan.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00361.
    >> Share

  308. EBANKS D, Faustini S, Shields A, Parry H, et al
    Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays.
    J Infect. 2021 Jul 26. pii: S0163-4453(21)00363.
    >> Share

  309. ROBERT TANNER A
    Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00365.
    >> Share

  310. GIDARI A, Sabbatini S, Bastianelli S, Pierucci S, et al
    Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00362.
    >> Share

  311. LAI CK, Lui GC, Chen Z, Cheung YY, et al
    Comparison of Self-collected Mouth Gargle with Deep-throat Saliva Samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19.
    J Infect. 2021 Jul 25. pii: S0163-4453(21)00354.
    >> Share

  312. BOU-KARROUM L, Khabsa J, Jabbour M, Hilal N, et al
    Public Health Effects of Travel-Related Policies on the COVID-19 Pandemic: A Mixed-Methods Systematic Review.
    J Infect. 2021 Jul 24. pii: S0163-4453(21)00360.
    >> Share

  313. LADHANI SN
    Crossing the Rubicon: a Fine Line between Waiting and Vaccinating Adolescents against COVID-19.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00357.
    >> Share

  314. GUDIOL C, Dura-Miralles X, Aguilar-Company J, Hernandez-Jimenez P, et al
    Co-infections and superinfections complicating COVID-19 in cancer patients: a multicenter, international study.
    J Infect. 2021 Jul 21. pii: S0163-4453(21)00356.
    >> Share

  315. GAO S, Lu Y, Luan J, Zhang L, et al
    Low incidence rate of diarrhoea in COVID-19 patients is due to integrin.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00348.
    >> Share

  316. MATTIUZZI C, Henry BM, Lippi G
    Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?: Symptoms of COVID-19.
    J Infect. 2021 Jul 15. pii: S0163-4453(21)00347.
    >> Share

  317. VANCHEESWARAN R, Willcox ML, Stuart B, Knight M, et al
    Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confirmed COVID-19.
    J Infect. 2021 Jul 14. pii: S0163-4453(21)00332.
    >> Share

  318. AVDEEV SN, Gaynitdinova VV, Merzhoeva ZM, Berikkhanov ZG, et al
    N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.
    J Infect. 2021 Jul 10. pii: S0163-4453(21)00329.
    >> Share

  319. NIITSU T, Shiroyama T, Hirata H, Noda Y, et al
    Cytomegalovirus infection in critically ill patients with COVID-19.
    J Infect. 2021 Jul 9. pii: S0163-4453(21)00330.
    >> Share

  320. ANGELETTI S, Giovanetti M, Fogolari M, De Florio L, et al
    Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated Health Care worker in Italy.
    J Infect. 2021 Jul 5. pii: S0163-4453(21)00325.
    >> Share

  321. FAVRESSE J, Douxfils J
    Importance of Sample Dilution in the Evaluation of the Antibody Response after SARS-CoV-2 Vaccination.
    J Infect. 2021 Jul 4. pii: S0163-4453(21)00327.
    >> Share

  322. ROCHA AS, Meireles M, Vilaca H, Guimaraes TC, et al
    Outcomes of Covid-19 Organizing Pneumonia in Critically Ill Patients: OUTCOMES OF COVID-19 ORGANIZING PNEUMONIA.
    J Infect. 2021 Jul 1. pii: S0163-4453(21)00322.
    >> Share

  323. BARBOSA GR, Moreira LVL, Justo AFO, Perosa AH, et al
    Rapid spread and high impact of the variant of concern P.1 in the largest city of Brazil.
    J Infect. 2021;83:119-145.
    >> Share

    June 2021
  324. XIE D, Chu H, Yang D, Ding Q, et al
    A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV.
    J Infect. 2021 Jun 30. pii: S0163-4453(21)00315.
    >> Share

  325. HSU L, Wisplinghoff H, Kossow A, Hurrass J, et al
    Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00320.
    >> Share

  326. SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
    Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    J Infect. 2021 Jun 29. pii: S0163-4453(21)00321.
    >> Share

  327. MENDEZ-BRITO A, Bcheraoui CE, Pozo-Martin F
    Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00316.
    >> Share

  328. TRE-HARDY M, Cupaiolo R, Wilmet A, Beukinga I, et al
    Waning antibodies in SARS-CoV-2 naive vaccinees: results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.
    J Infect. 2021 Jun 20. pii: S0163-4453(21)00314.
    >> Share

  329. BUSKERMOLEN M, Te Paske K, van Beek J, Kortbeek T, et al
    Relapse in the first 8 weeks after onset of COVID-19 disease in outpatients: viral reactivation or inflammatory rebound?
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00310.
    >> Share

  330. DIMEGLIO C, Herin F, Miedouge M, Da-Silva I, et al
    One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.
    J Infect. 2021 Jun 17. pii: S0163-4453(21)00312.
    >> Share

  331. HOMMA Y, Katsuta T, Oka H, Inoue K, et al
    The incubation period of the SARS-CoV-2 B.1.1.7 variant is shorter than that of other strains.
    J Infect. 2021 Jun 16. pii: S0163-4453(21)00306.
    >> Share

  332. ANDERSEN MP, Ostergaard L, Phelps M, Butt JH, et al
    Risk of Coronavirus Disease 2019 (Covid-19) Contraction and Severe Infection in Home- or Healthcare Professionals.
    J Infect. 2021 Jun 15. pii: S0163-4453(21)00305.
    >> Share

  333. CENDEJAS-BUENO E, Romero-Gomez MP, Escosa L, Jimenez-Rodriguez S, et al
    Lower nasopharyngeal viral loads in pediatric population. The missing piece to understand SARS-CoV-2 infection in children?
    J Infect. 2021 Jun 13. pii: S0163-4453(21)00289.
    >> Share

  334. LOFFREDO L, Oliva A, Paraninfi A, Ceccarelli G, et al
    An observed association between conjunctivitis and severity of COVID-19.
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00286.
    >> Share

  335. KWOK KO, McNeil EB, Tsoi MTF, Wei VWI, et al
    Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    J Infect. 2021 Jun 9. pii: S0163-4453(21)00287.
    >> Share

  336. NOH JY, Song JY, Hyun HJ, Yoon JG, et al
    Risk factors for SARS-CoV-2 transmission in non-household clusters.
    J Infect. 2021 Jun 8. pii: S0163-4453(21)00284.
    >> Share

  337. RISTIC S, Pavlic SD, Nadalin S, Cizmarevic NS, et al
    ACE I/D polymorphism and epidemiological findings for COVID-19: one year after the pandemic outbreak in Europe.
    J Infect. 2021 Jun 4. pii: S0163-4453(21)00282.
    >> Share

  338. LORENZO VB, Nascimento-Carvalho C
    Differences between children with severe acute lower respiratory infection with or without SARS-Cov-2 infection.
    J Infect. 2021 Jun 3. pii: S0163-4453(21)00280.
    >> Share

  339. FANTINI J, Yahi N, Azzaz F, Chahinian H, et al
    Structural dynamics of SARS-CoV-2 variants: a health monitoring strategy for anticipating Covid-19 outbreaks.
    J Infect. 2021 Jun 2. pii: S0163-4453(21)00281.
    >> Share

  340. OLEA B, Albert E, Torres I, Gozalvo-Rovira R, et al
    Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: relationship with biomarkers of disease severity.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00279.
    >> Share

  341. STANG A, Robers J, Schonert B, Jockel KH, et al
    The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.
    J Infect. 2021 Jun 1. pii: S0163-4453(21)00265.
    >> Share

    May 2021
  342. YAN X, Huang H, Wang C, Jin Z, et al
    Follow-up study of pulmonary function among COVID-19 survivors 1 year after recovery.
    J Infect. 2021 May 29. pii: S0163-4453(21)00276.
    >> Share

  343. KONTOGIANNI K, Cubas-Atienzar AI, Wooding D, Buist K, et al
    Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B.1.1.7 lineage.
    J Infect. 2021 May 29. pii: S0163-4453(21)00272.
    >> Share

  344. RAW RK, Kelly C, Rees J, Wroe C, et al
    Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.
    J Infect. 2021 May 29. pii: S0163-4453(21)00277.
    >> Share

  345. ZHANG N, Chen X, Jia W, Jin T, et al
    Evidence for lack of transmission by close contact and surface touch in a restaurant outbreak of COVID-19.
    J Infect. 2021 May 29. pii: S0163-4453(21)00273.
    >> Share

  346. TANG JW, Bird PW, Holmes CW, Nicoara DC, et al
    The UK Leicester COVID-19 'exceedance' May-July 2020: An analysis of hospitalised cases.
    J Infect. 2021 May 29. pii: S0163-4453(21)00270.
    >> Share

  347. PEZZATI L, Giacomelli A, Mileto D, Conti F, et al
    Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: a cross-sectional study.: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
    J Infect. 2021 May 29. pii: S0163-4453(21)00271.
    >> Share

  348. THANGARAJ JWV, Kumar MS, Kumar CG, Kumar VS, et al
    Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.
    J Infect. 2021 May 28. pii: S0163-4453(21)00268.
    >> Share

  349. BUTT AA, Khan T, Yan P, Shaikh OS, et al
    Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.
    J Infect. 2021 May 28. pii: S0163-4453(21)00263.
    >> Share

  350. PALLOTTO C, Blanc P, Esperti S, Suardi LR, et al
    Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19).
    J Infect. 2021 May 28. pii: S0163-4453(21)00267.
    >> Share

  351. BREATHNACH AS, Duncan CJA, Bouzidi KE, Hanrath AT, et al
    Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies.
    J Infect. 2021 May 27. pii: S0163-4453(21)00266.
    >> Share

  352. CAPETTI AF, Borgonovo F, Mileto D, Gagliardi G, et al
    One-year durability of anti-spike IgG to SARS-CoV-2: preliminary data from the AntiCROWN prospective observational study One year durability of COVID-19 anti-spike IgG.
    J Infect. 2021 May 27. pii: S0163-4453(21)00264.
    >> Share

  353. VENTURAS J, Zamparini J, Shaddock E, Stacey S, et al
    Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.
    J Infect. 2021 May 26. pii: S0163-4453(21)00262.
    >> Share

  354. J BP, Jolly B, John N, Bhoyar RC, et al
    Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
    J Infect. 2021 May 24. pii: S0163-4453(21)00260.
    >> Share

  355. YAMAMOTO S, Tanaka A, Oshiro Y, Ishii M, et al
    Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    J Infect. 2021 May 24. pii: S0163-4453(21)00259.
    >> Share

  356. SZARPAK L
    Mucormycosis - a serious threat in the COVID-19 pandemic?
    J Infect. 2021 May 21. pii: S0163-4453(21)00257.
    >> Share

  357. HASAN MJ, Rabbani R, Anam AM, Huq SMR, et al
    Secukinumab in severe COVID-19 pneumonia: does it have a clinical impact?: Secukinumab in severe COVID-19.
    J Infect. 2021 May 21. pii: S0163-4453(21)00253.
    >> Share

  358. FONSECA V, de Jesus R, Adelino T, Reis AB, et al
    Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil.
    J Infect. 2021 May 21. pii: S0163-4453(21)00256.
    >> Share

  359. CARAMELLO V, Boccuzzi A, Basile V, Ferraro A, et al
    Are antigenic tests useful for detecting SARS-CoV-2 infections in patients accessing to emergency departments? Results from a North-West Italy Hospital.
    J Infect. 2021 May 20. pii: S0163-4453(21)00255.
    >> Share

  360. BORDI L, Parisi G, Sberna G, Amendola A, et al
    Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: a pilot project.
    J Infect. 2021 May 20. pii: S0163-4453(21)00254.
    >> Share

  361. ZARIF A, Joy M, Sherlock J, Sheppard JP, et al
    The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    J Infect. 2021 May 15. pii: S0163-4453(21)00220.
    >> Share

  362. HOTHAM M
    Potential future implications of the COVID-19 pandemic on Norovirus infections in England.
    J Infect. 2021 May 13. pii: S0163-4453(21)00241.
    >> Share

  363. CHIRICO F, Nucera G, Szarpak L
    COVID-19 mortality in Italy: The first wave was more severe and deadly, but only in Lombardy region.
    J Infect. 2021 May 13. pii: S0163-4453(21)00248.
    >> Share

  364. KOROMPOKI E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, et al
    Epidemiology and organ specific sequelae of post-acute COVID19: A Narrative Review.
    J Infect. 2021 May 13. pii: S0163-4453(21)00247.
    >> Share

  365. MANN JA, Bird PW, Bandi S, Tang JW, et al
    Asymptomatic SARS-CoV-2-infected children attending hospital with non-COVID-19 diagnoses, March 2020-February 2021.
    J Infect. 2021 May 13. pii: S0163-4453(21)00240.
    >> Share

  366. WINCHESTER S, John S, Jabbar K, John I, et al
    Clinical Efficacy of Nitric Oxide Nasal Spray (NONS) for the Treatment of Mild COVID-19 Infection.
    J Infect. 2021 May 13. pii: S0163-4453(21)00251.
    >> Share

  367. KOW CS, Merchant HA, Hasan SS
    Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK.
    J Infect. 2021 May 13. pii: S0163-4453(21)00250.
    >> Share

  368. WHITAKER HJ, Elgohari S, Rowe C, Otter AD, et al
    Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
    J Infect. 2021 May 11. pii: S0163-4453(21)00224.
    >> Share

  369. FERNANDEZ-VILLA T, Vazquez-Casares A, Rivero-Rodriguez A, Carvajal-Urena A, et al
    Rapid antigen test for SARS-CoV-2 and primary health care.
    J Infect. 2021 May 7. pii: S0163-4453(21)00226.
    >> Share

  370. SANSONE E, Tiraboschi M, Sala E, Albini E, et al
    Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
    J Infect. 2021 May 6. pii: S0163-4453(21)00225.
    >> Share

  371. MACLOT F, Bontems S, Meex C, Artesi M, et al
    Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant.
    J Infect. 2021 May 3. pii: S0163-4453(21)00221.
    >> Share

  372. MATAKI N, Ohmura H, Kodama T, Nakamura S, et al
    Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19.
    J Infect. 2021;82:186-230.
    >> Share

  373. RICCO M, Ranzieri S, Marchesi F
    Rapid antigen tests for large-scale diagnostic campaigns: A case study from North-Eastern Italy.
    J Infect. 2021;82:e39-e40.
    >> Share

    April 2021
  374. DE PAULA CSY, Palandri GG, Fonseca TS, Vendramini TCA, et al
    Gastrointestinal manifestations are associated with severe pediatric COVID-19: a study in tertiary hospital.
    J Infect. 2021 Apr 30. pii: S0163-4453(21)00217.
    >> Share

  375. GARVEY MI, Wilkinson MAC, Holden E, Shields A, et al
    Early observations on the impact of a healthcare worker COVID-19 vaccination programme at a major UK tertiary centre.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00214.
    >> Share

  376. CHUDASAMA DY, Flannagan J, Collin SM, Charlett A, et al
    Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012-01) in England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00216.
    >> Share

  377. VUSIRIKALA A, Whitaker H, Jones S, Tessier E, et al
    Seroprevalence of SARS-CoV-2 Antibodies in University Students: cross-sectional study, December 2020, England.
    J Infect. 2021 Apr 29. pii: S0163-4453(21)00215.
    >> Share

  378. TEYSSOU E, Soulie C, Visseaux B, Lambert-Niclot S, et al
    The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00211.
    >> Share

  379. BAEK YJ, Lee YJ, Yoon JS, Sohn Y, et al
    Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: a longitudinal study.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00212.
    >> Share

  380. GARVEY MI, McMurray C, Casey AL, Ratcliffe L, et al
    Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital Trust.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00213.
    >> Share

  381. BONGIOVANNI M, Arienti R, Bini F, Bodini BD, et al
    Differences between the waves in Northern Italy: how the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed.
    J Infect. 2021 Apr 28. pii: S0163-4453(21)00210.
    >> Share

  382. GALOW L, Haag L, Kahre E, Blankenburg J, et al
    Lower household transmission rates of SARS-CoV-2 from children compared to adults.
    J Infect. 2021 Apr 27. pii: S0163-4453(21)00209.
    >> Share

  383. MARTIN-SANCHEZ M, Lim WW, Yeung A, Adam DC, et al
    COVID-19 transmission in Hong Kong despite universal masking.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00205.
    >> Share

  384. LI KK, Woo YM, Stirrup O, Hughes J, et al
    Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00206.
    >> Share

  385. CHEN S, Zhang X, Zhou Y, Yang K, et al
    COVID-19 protective measures prevent the spread of respiratory and intestinal infectious diseases but not sexually transmitted and bloodborne diseases.
    J Infect. 2021 Apr 22. pii: S0163-4453(21)00204.
    >> Share

  386. FAROOQ HZ, Davies E, Brown B, Whitfield T, et al
    Real-world SARS CoV-2 Testing in Northern England during the first wave of the COVID-19 Pandemic.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00199.
    >> Share

  387. STOCKDALE AJ, Fyles F, Farrell C, Lewis J, et al
    Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard: Clinical sensitivity of SARS-CoV-2 PCR.
    J Infect. 2021 Apr 20. pii: S0163-4453(21)00198.
    >> Share

  388. FU H, Zhang N, Zheng Y, Jiang N, et al
    Risk stratification of cardiac sequelae detected using cardiac magnetic resonance in late convalescence at the six-month follow-up of recovered COVID-19 patients.
    J Infect. 2021 Apr 19. pii: S0163-4453(21)00202.
    >> Share

  389. BARO B, Rodo P, Ouchi D, Bordoy AE, et al
    Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison.
    J Infect. 2021 Apr 18. pii: S0163-4453(21)00191.
    >> Share

  390. KODANA M, Kitagawa Y, Takahashi R, Matsuoka M, et al
    Concerns about the clinical usefulness of saliva specimens 1 for the diagnosis of COVID-19.
    J Infect. 2021 Apr 16. pii: S0163-4453(21)00194.
    >> Share

  391. ALCOBA-FLOREZ J, Lorenzo-Salazar JM, Gil-Campesino H, Inigo-Campos A, et al
    Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020.
    J Infect. 2021 Apr 12. pii: S0163-4453(21)00168.
    >> Share

  392. DONADIO C, Rainone A, Gouronnec A, Belmin J, et al
    Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: a case series in a geriatric rehabilitation ward during an outbreak.
    J Infect. 2021 Apr 11. pii: S0163-4453(21)00167.
    >> Share

  393. BONGIOVANNI M, Marra AM, Bini F, Bodini BD, et al
    COVID-19 reinfection in healthcare workers: a case series.
    J Infect. 2021 Apr 8. pii: S0163-4453(21)00165.
    >> Share

  394. LIU Y, Chen H, Tan W, Kuang Y, et al
    Clinical characteristics and outcome of SARS-CoV-2 infection during pregnancy.
    J Infect. 2021 Apr 5. pii: S0163-4453(21)00163.
    >> Share

  395. TABOADA M, Gonzalez M, Alvarez A, Eiras M, et al
    First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00160.
    >> Share

  396. NAYAGAM JS, Jeyaraj R, Mitchell T, Walder DP, et al
    Persistent cholestasis in survivors of SARS-CoV-2.
    J Infect. 2021 Apr 4. pii: S0163-4453(21)00162.
    >> Share

  397. OGURI S, Fujisawa S, Kamada K, Nakakubo S, et al
    Effect of varying storage conditions on diagnostic test outcomes of SARS-CoV-2.
    J Infect. 2021 Apr 3. pii: S0163-4453(21)00159.
    >> Share

  398. GARCIA-PACHON E, Grau-Delgado J, Soler-Sempere MJ, Zamora-Molina L, et al
    Low prevalence of post-COVID-19 syndrome in patients with asthma.
    J Infect. 2021 Apr 2. pii: S0163-4453(21)00156.
    >> Share

    March 2021
  399. TRE-HARDY M, Cupaiolo R, Papleux E, Wilmet A, et al
    Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers.
    J Infect. 2021 Mar 31. pii: S0163-4453(21)00158.
    >> Share

  400. MASIA M, Padilla S, Galiana A, Fernandez-Gonzalez M, et al
    Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study.
    J Infect. 2021 Mar 29. pii: S0163-4453(21)00152.
    >> Share

  401. PILLAI A, Koduri K, Gokhale Y, Venkatesh M, et al
    Covid-19 Letter to the Editor.
    J Infect. 2021 Mar 28. pii: S0163-4453(21)00154.
    >> Share

  402. MULCHANDANI R, Taylor-Philips S, Jones HE, Ades AE, et al
    Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers.
    J Infect. 2021 Mar 25. pii: S0163-4453(21)00151.
    >> Share

  403. WILLIAMS CM, Pan D, Decker J, Wisniewska A, et al
    Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with covid-19.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00135.
    >> Share

  404. CHAU DNVV
    Rapid whole-genome sequencing to inform COVID-19 outbreak response in Vietnam.
    J Infect. 2021 Mar 24. pii: S0163-4453(21)00133.
    >> Share

  405. HARRIS RJ, Whitaker HJ, Andrews NJ, Aiano F, et al
    Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00132.
    >> Share

  406. HIROTSU Y, Omata M
    Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
    J Infect. 2021 Mar 22. pii: S0163-4453(21)00130.
    >> Share

  407. MURRAY MJ, McIntosh M, Atkinson C, Mahungu T, et al
    Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay.
    J Infect. 2021 Mar 19. pii: S0163-4453(21)00127.
    >> Share

  408. THARMARAJAH E, Buazon A, Patel V, Hannah JR, et al
    IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00125.
    >> Share

  409. WILLIAMS P, McWilliams C, Soomro K, Harding I, et al
    The dynamics of procalcitonin in COVID-19 patients admitted to Intensive Care Unit - A multi-centre cohort study in the South West of England, UK.
    J Infect. 2021 Mar 18. pii: S0163-4453(21)00128.
    >> Share

  410. BIRD PW, Holmes C, Fletcher O, Badhwar V, et al
    Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence: A cautionary tale.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00124.
    >> Share

  411. GARVEY MI, Casey AL, Wilkinson MAC, Ratcliffe L, et al
    Details of SARS-CoV-2 reinfections at a major UK tertiary centre.
    J Infect. 2021 Mar 17. pii: S0163-4453(21)00122.
    >> Share

  412. REBOIRO MLL, Fuentetaja RS, Lopez RG, Castro-Conde BA, et al
    Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19.
    J Infect. 2021 Mar 15. pii: S0163-4453(21)00123.
    >> Share

  413. CHAUDHRY Z, Shawe-Taylor M, Rampling T, Cutfield T, et al
    Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate.
    J Infect. 2021 Mar 11. pii: S0163-4453(21)00115.
    >> Share

  414. YANG H, Hou H, Liang X, Xu J, et al
    Lack of significant association between dyslipidemia and COVID-19 mortality.
    J Infect. 2021 Mar 5. pii: S0163-4453(21)00114.
    >> Share

  415. MARTYN EM, Whitaker H, Gil E, Ighomereho P, et al
    Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital.
    J Infect. 2021 Mar 4. pii: S0163-4453(21)00098.
    >> Share

  416. YOUNG BC, Eyre DW, Jeffery K
    Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00096.
    >> Share

  417. BADDAL B, Bostanci A, Suer K, Sanlidag T, et al
    SARS-CoV-2 was already in circulation in Northern Cyprus in the prepandemic period.
    J Infect. 2021 Mar 1. pii: S0163-4453(21)00097.
    >> Share

    February 2021
  418. PETRONE L, Petruccioli E, Alonzi T, Vanini V, et al
    In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00094.
    >> Share

  419. MENSAH AA, Sinnathamby M, Zaidi A, Coughlan L, et al
    SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: prospective, national observational cohort surveillance, July-December 2020, England.
    J Infect. 2021 Feb 24. pii: S0163-4453(21)00093.
    >> Share

  420. DENNY S, Abdolrasouli A, Elamin T, Gonzalo X, et al
    A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave.
    J Infect. 2021 Feb 18. pii: S0163-4453(21)00090.
    >> Share

  421. SCIMECA M, Mauriello S, Servadei F, Caggiano B, et al
    Persistence of SARS-CoV-2 viral RNA in nasopharyngeal swabs after death.
    J Infect. 2021 Feb 17. pii: S0163-4453(21)00083.
    >> Share

  422. ANTONELLI M, Capdevila J, Chaudhari A, Granerod J, et al
    Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00079.
    >> Share

  423. BULILETE O, Lorente P, Leiva A, Carandell E, et al
    Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00080.
    >> Share

  424. TORRES I, Poujois S, Albert E, Alvarez G, et al
    Point-of-care evaluation of a rapid antigen test (CLINITEST() Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals.
    J Infect. 2021 Feb 12. pii: S0163-4453(21)00075.
    >> Share

  425. YANG H, Liang X, Hou H, Xu J, et al
    The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00078.
    >> Share

  426. LORA-TAMAYO J, Maestro G, Lalueza A, Rubio-Rivas M, et al
    Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study.
    J Infect. 2021 Feb 11. pii: S0163-4453(21)00077.
    >> Share

  427. NADAL M, Lassel L, Denis M, Gibelin A, et al
    ROLE OF SUPER-SPREADER PHENOMENON IN A COVID-19 CLUSTER AMONG HEALTHCARE WORKERS IN A PRIMARY CARE HOSPITAL.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00074.
    >> Share

  428. SCUTT DG, Overall DA
    Single nucleotide polymorphisms in key aging pathways, and phenotypic markers of frailty are associated with increased odds of hospital admission with COVID-19.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00056.
    >> Share

  429. EIGNER U, Verstraeten T, Weil J
    Decrease in Norovirus infections in Germany following COVID-19 containment measures.
    J Infect. 2021 Feb 10. pii: S0163-4453(21)00076.
    >> Share

  430. KEVORKIAN JP, Lopes A, Sene D, Riveline JP, et al
    Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00058.
    >> Share

  431. ADRIELLE DOS SANTOS L, Filho PGG, Silva AMF, Santos JVG, et al
    Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00043.
    >> Share

  432. LI G, Niu J, Fan X, Chen T, et al
    The chilly climate may increase the chance of infecting COVID-19.
    J Infect. 2021 Feb 8. pii: S0163-4453(21)00057.
    >> Share

  433. DE MONTMOLLIN E, Faille D, Andrieu V, Ajzenberg N, et al
    Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    J Infect. 2021 Feb 5. pii: S0163-4453(21)00054.
    >> Share

  434. MORALES-ORTEGA A, Rivas-Prado L, Frutos-Perez B, Jaenes-Barrios B, et al
    Early clinical experience with imatinib in COVID-19: searching for a dual effect.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00051.
    >> Share

  435. BELSKY JA, Tullius BP, Lamb MG, Sayegh R, et al
    COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00045.
    >> Share

  436. TOOVEY OTR, Harvey KN, Bird PW, Tang JWW, et al
    Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00047.
    >> Share

  437. BORGONOVO F, Passerini M, Piscaglia M, Morena V, et al
    Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
    J Infect. 2021 Feb 3. pii: S0163-4453(21)00048.
    >> Share

  438. WILSON-DAVIES ESW, Mahanama AIK, Samaraweera B, Ahmed N, et al
    Concerns regarding the sensitivity of the OptiGene direct SARS-CoV-2 LAMP assay and its suitability for use in at-risk groups and hospital staff.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00036.
    >> Share

  439. ALMHAWISH N, Karah N, Elferruh Y, Aksh A, et al
    Protecting healthcare workers in conflict zones during the COVID-19 pandemic: northwest Syria.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00046.
    >> Share

  440. TUBIANA S, Burdet C, Houhou N, Thy M, et al
    High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in in-hospital workers - the CoV-CONTACT cohort.
    J Infect. 2021 Feb 2. pii: S0163-4453(21)00049.
    >> Share

  441. FOWLER DV, Douglas DA, Godfrey PK, Williams PA, et al
    Critical evaluation of the methodology used by Wilson-Davies et al., (2020) entitled "Concerning the Optigene Direct LAMP assay, and it`s use in at-risk groups and hospital staff".
    J Infect. 2021;82:282-327.
    >> Share

    January 2021
  442. DIMEGLIO C, Miedouge M, Loubes JM, Mansuy JM, et al
    Side effect of a 6 p.m curfew for preventing the spread of SARS-CoV-2: a modelling study from Toulouse, France.
    J Infect. 2021 Jan 31. pii: S0163-4453(21)00044.
    >> Share

  443. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00041.
    >> Share

  444. TANAKA A, Yamamoto S, Miyo K, Mizoue T, et al
    Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
    J Infect. 2021 Jan 29. pii: S0163-4453(21)00032.
    >> Share

  445. T U, Am DR, Bm W, Ar H, et al
    Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients.
    J Infect. 2021 Jan 28. pii: S0163-4453(21)00040.
    >> Share

  446. DOWNS LO, Eyre DW, O'Donnell D, Jeffery K, et al
    Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers.
    J Infect. 2021 Jan 25. pii: S0163-4453(21)00033.
    >> Share

  447. ADACHI Y, Shiroyama T, Yamaguchi Y, Murakami T, et al
    Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study: Running head: Factors predicting respiratory failure in COVID-19.
    J Infect. 2021 Jan 24. pii: S0163-4453(21)00039.
    >> Share

  448. ELFIKY AA, Ibrahim IM
    Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.
    J Infect. 2021 Jan 22. pii: S0163-4453(21)00038.
    >> Share

  449. DE FRANCESCO MA, Poiesi C, Gargiulo F, Bonfanti C, et al
    Co-infection of Chlamydia pneumoniae and Mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features.
    J Infect. 2021 Jan 19. pii: S0163-4453(21)00031.
    >> Share

  450. TANG JW, Toovey OTR, Harvey KN, Hui DDS, et al
    Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK.
    J Infect. 2021 Jan 17. pii: S0163-4453(21)00030.
    >> Share

  451. BREATHNACH DAS, Riley PA, Cotter MP, Houston AC, et al
    Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00010.
    >> Share

  452. MORENO-PEREZ O, Merino E, Leon-Ramirez JM, Andres M, et al
    Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00009.
    >> Share

  453. GARCIA-ORTEGA A, Oscullo G, Calvillo P, Lopez-Reyes R, et al
    INCIDENCE, RISK FACTORS, AND THROMBOTIC LOAD OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR COVID-19 INFECTION.
    J Infect. 2021 Jan 10. pii: S0163-4453(21)00007.
    >> Share

  454. GARRATT AM, Ghanima W, Einvik G, Stavem K, et al
    Quality of life after COVID-19 without hospitalisation: good overall, but reduced in some dimensions.
    J Infect. 2021 Jan 9. pii: S0163-4453(21)00006.
    >> Share

  455. ALEMANY A, Baro B, Ouchi D, Rodo P, et al
    Analytical and Clinical Performance of the Panbio COVID-19 Antigen-Detecting Rapid Diagnostic Test.
    J Infect. 2021 Jan 6. pii: S0163-4453(21)00004.
    >> Share

  456. NISHI A, Lee LF, Tsuji H, Takasaki Y, et al
    Letter to the Editor: Revisiting the County/city-level Event Risk Assessment during the COVID-19 Pandemic.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00003.
    >> Share

  457. BONGIOVANNI M, Bini F, Giuliani G, Gianturco L, et al
    Insight into the reason of prolonged viral RNA shedding in patients with COVID-19 infection.
    J Infect. 2021 Jan 3. pii: S0163-4453(21)00002.
    >> Share

  458. XIE Y, Chen Y, Ma M, He D, et al
    Re-emergence of coronavirus disease in Chinese cities associated with chilled and frozen food products.
    J Infect. 2021 Jan 2. pii: S0163-4453(20)30789.
    >> Share

    December 2020
  459. LIU Y, Li M, Liu D, Luo JF, et al
    Developing a multivariable risk prediction model to predict prolonged viral clearance in patients with COVID-19.
    J Infect. 2020 Dec 30. pii: S0163-4453(20)30787.
    >> Share

  460. TANG JW, Tambyah PA, Hui DS
    Emergence of a new SARS-CoV-2 variant in the UK.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30786.
    >> Share

  461. YANG H, Xu J, Liang X, Shi L, et al
    Autoimmune diseases are independently associated with COVID-19 severity: Evidence based on adjusted effect estimates.
    J Infect. 2020 Dec 28. pii: S0163-4453(20)30785.
    >> Share

  462. HANRATH AT, Payne BAI, Duncan CJA, van der Loeff IS, et al
    Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30781.
    >> Share

  463. CHAN HT, Chao CM, Lai CC
    Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: a meta-analysis.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30783.
    >> Share

  464. TABOADA M, Carinena A, Moreno E, Rodriguez N, et al
    Post-COVID-19 functional status six-months after Hospitalization.: Functional status after COVID-19.
    J Infect. 2020 Dec 26. pii: S0163-4453(20)30784.
    >> Share

  465. KONIG S, Hohenstein S, Ueberham L, Hindricks G, et al
    Regional and temporal disparities of excess all-cause mortality for Germany in 2020: Is there more than just COVID-19?
    J Infect. 2020 Dec 23. pii: S0163-4453(20)30777.
    >> Share

  466. WILSON-DAVIES DESW, Mahanama DAIK, Samaraweera DB, Ahmed DN, et al
    Insensitivity of the 'Moonshot' LAMP assay, unsuitable for use in at-risk groups and hospital staff.
    J Infect. 2020 Dec 22. pii: S0163-4453(20)30778.
    >> Share

  467. GANDINI O, Lubrano C
    Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.
    J Infect. 2020 Dec 20. pii: S0163-4453(20)30775.
    >> Share

  468. TURCATO G, Zaboli A, Pfeifer N, Ciccariello L, et al
    Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report.
    J Infect. 2020 Dec 18. pii: S0163-4453(20)30773.
    >> Share

  469. BELLANTI F, Buglio AL, Custodero G, Barbera L, et al
    Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient.
    J Infect. 2020 Dec 16. pii: S0163-4453(20)30770.
    >> Share

  470. AGULLO V, Fernandez-Gonzalez M, Ortiz de la Tabla V, Gonzalo-Jimenez N, et al
    Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study.
    J Infect. 2020 Dec 9. pii: S0163-4453(20)30768.
    >> Share

  471. ZHOU H, Li C, Hu T, Liu T, et al
    Total Infectomes of 162 SARS-CoV-2 Cases Using Meta-Transcriptomic Sequencing.
    J Infect. 2020 Dec 8. pii: S0163-4453(20)30765.
    >> Share

  472. CHEN PJ, Chao CM, Lai CC
    Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients.
    J Infect. 2020 Dec 7. pii: S0163-4453(20)30766.
    >> Share

  473. BARRASA H, Martin A, Maynar J, Rello J, et al
    High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: a matter of time?
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30761.
    >> Share

  474. SALMON D, Slama D, De Broucker T, Karmochkine M, et al
    Clinical, virological and imaging profile in patients with Persistent or Resurgent forms of COVID-19: a cross-sectional study.
    J Infect. 2020 Dec 4. pii: S0163-4453(20)30762.
    >> Share

  475. FRICKE LM, Glockner S, Dreier M, Lange B, et al
    Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review.
    J Infect. 2020 Dec 2. pii: S0163-4453(20)30756.
    >> Share

  476. FALCINELLI E, Petito E, Becattini C, De Robertis E, et al
    Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30760.
    >> Share

  477. PIOVANI D, Christodoulou MN, Hadjidemetriou A, Pantavou K, et al
    Effect of early application of social distancing interventions on Covid-19 mortality over the first pandemic wave: an analysis of longitudinal data from 37 countries.
    J Infect. 2020 Dec 1. pii: S0163-4453(20)30751.
    >> Share

  478. PANDEY M, Sisodia S, Bandi S, Roland D, et al
    Incidence of spread of clinically relevant SARS-CoV2 infection between children in a tertiary emergency department: An evaluation.
    J Infect. 2020;81:979-997.
    >> Share

    November 2020
  479. FURUSE Y
    Risk at mass-gathering events and the usefulness of complementary events during COVID-19 pandemic.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30759.
    >> Share

  480. MOREIRA LVL, de Souza Luna LK, Barbosa GR, Perosa AH, et al
    Test on stool samples improves the diagnosis of hospitalized patients: detection of SARS-CoV-2 genomic and subgenomic RNA.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30753.
    >> Share

  481. MAANI AA, Al-Jardani A, Karrar H, Petersen E, et al
    COVID-19 in a case previously infected with MERS-CoV: no cross immunity.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30754.
    >> Share

  482. GURGEL RQ, de Sa LC, Souza DRV, Martins AF, et al
    SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30752.
    >> Share

  483. DUBOUCHER C
    SARS-CoV-2 and superimposed infection by trichomonads.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30757.
    >> Share

  484. JONES CR, Hamilton FW, Thompson A, Morris TT, et al
    SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30755.
    >> Share

  485. FOWLER VL, Armson B, Gonzales JL, Wise EL, et al
    A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30731.
    >> Share

  486. LIU D, Yang J, Feng B, Lu W, et al
    Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of COVID-19.
    J Infect. 2020 Nov 28. pii: S0163-4453(20)30726.
    >> Share

  487. LAI CC, Chen SY, Yen MY, Lee PI, et al
    The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan.
    J Infect. 2020 Nov 26. pii: S0163-4453(20)30724.
    >> Share

  488. LEVI M, Miglietta A, Romeo G, Bartolacci S, et al
    Letter in response to article in Journal of Infection: Impact of Routine Infant BCG Vaccination on COVID-19.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30718.
    >> Share

  489. BERASTEGUI-CABRERA J, Salto-Alejandre S, Valerio M, Perez-Palacios P, et al
    SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30719.
    >> Share

  490. SUI Z, Zhang Y, Tu J, Xie J, et al
    Evaluation of saliva as an alternative diagnostic specimen source for SARS-CoV-2 detection by RT-dPCR.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30716.
    >> Share

  491. ROMERO-GOMEZ MP, Gomez-Sebastian S, Cendejas-Bueno E, Montero-Vega MD, et al
    Ct value is not enough to discriminate patients harbouring infective virus.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30720.
    >> Share

  492. MAJRA D, Benson J, Pitts J, Stebbing J, et al
    SARS-CoV-2 (COVID-19) Superspreader Events.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30717.
    >> Share

  493. KOWALL B, Nonnemacher M, Brune B, Brinkmann M, et al
    A model to identify individuals with a high probability of a SARS-CoV-2 infection.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30721.
    >> Share

  494. VOICU S, Chousterman BG, Bonnin P, Deye N, et al
    Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19.
    J Infect. 2020 Nov 20. pii: S0163-4453(20)30714.
    >> Share

  495. CHAU NVV, Toan LM, Man DNH, Thao HP, et al
    Absence of SARS-CoV-2 antibodies in health care workers of a tertiary referral hospital for COVID-19 in southern Vietnam.
    J Infect. 2020 Nov 19. pii: S0163-4453(20)30713.
    >> Share

  496. XIONG X, Jiao X, Li H, Zeng S, et al
    Glucocorticoid benefits the ventilatory function of sever/critical COVID-19 patients.
    J Infect. 2020 Nov 18. pii: S0163-4453(20)30712.
    >> Share

  497. BAUER W, Diehl-Wiesenecker E, Ulke J, Galtung N, et al
    Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30711.
    >> Share

  498. TORRES M, Collins K, Corbit M, Ramirez M, et al
    Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30710.
    >> Share

  499. COLSON P, Finaud M, Levy N, Lagier JC, et al
    Evidence of SARS-CoV-2 re-infection with a different genotype.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30706.
    >> Share

  500. POOLE S, Brendish NJ, Clark TW
    SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30707.
    >> Share

  501. AUNG AK, Aitken T, Teh BM, Yu C, et al
    Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.
    J Infect. 2020 Nov 14. pii: S0163-4453(20)30708.
    >> Share

  502. HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
    Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.
    >> Share

  503. RANA MS
    Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30705.
    >> Share

  504. GARDINER T, Cooke G, Fidler S, Cooper N, et al
    The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30699.
    >> Share

  505. CHAN RWY, Chan KC, Chan KYY, Lui GCY, et al
    SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30704.
    >> Share

  506. YAN Y, Jiang X, Fu J, Huang J, et al
    Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30701.
    >> Share

  507. CHARLTON M, Dashey S, Stubbs A, Lai FY, et al
    Comparing SARS-CoV-2 and influenza A(H1N1)pdm09-infected patients requiring ECMO - a single-centre, retrospective observational cohort experience.
    J Infect. 2020 Nov 9. pii: S0163-4453(20)30698.
    >> Share

  508. JI J, Wu M, Zhong L, Liu Z, et al
    Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: a multicenter retrospective cohort study.
    J Infect. 2020 Nov 8. pii: S0163-4453(20)30696.
    >> Share

  509. ROWLAND TAJ, Whitaker H, Jeffery-Smith A, Lang N, et al
    Seropositivity and risk factors for SARS-CoV-2 infection in staff working in care homes during the COVID-19 pandemic.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30695.
    >> Share

  510. ALANIO A, Delliere S, Voicu S, Bretagne S, et al
    The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
    J Infect. 2020 Nov 4. pii: S0163-4453(20)30694.
    >> Share

  511. SAITO S, Asai Y, Matsunaga N, Hayakawa K, et al
    First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics: Comparison of the two COVID-19 waves in Japan.
    J Infect. 2020 Nov 2. pii: S0163-4453(20)30693.
    >> Share

  512. SCHIRINZI A, Pesce F, Laterza R, D'Alise MG, et al
    Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department.
    J Infect. 2020 Nov 1. pii: S0163-4453(20)30687.
    >> Share

    October 2020
  513. HAMED E
    Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30691.
    >> Share

  514. WANG X, Lin L, Xuan Z, Xu J, et al
    Risk communication on behavioral responses during COVID-19 among general population in China: a rapid national study.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30689.
    >> Share

  515. DIMEGLIO C, Loubes JM, Mansuy JM, Izopet J, et al
    Quantifying the impact of public health protection measures on the spread of SARS-CoV-2.
    J Infect. 2020 Oct 28. pii: S0163-4453(20)30686.
    >> Share

  516. ARAN D, Beachler DC, Lanes S, Overhage JM, et al
    Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30683.
    >> Share

  517. MERLI M, Pasulo L, Perricone G, Travi G, et al
    Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30685.
    >> Share

  518. GUETL K, Moazedi-Fuerst F, Rosskopf K, Brodmann M, et al
    SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30684.
    >> Share

  519. CHEN CH, Lai CC, Chao CM, Tang HJ, et al
    Zero measles after COVID-19 pandemic in Taiwan Running title: measles and COVID-19.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30679.
    >> Share

  520. ALFEHAIDI A, Ahmed SA, Hamed E
    A case of SARS-CoV-2 re-infection.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30677.
    >> Share

  521. MASIA M, Fernandez-Gonzalez M, Garcia JA, Padilla S, et al
    Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30676.
    >> Share

  522. MORFELD P, Timmermann B, Gross JV, DeMatteis S, et al
    COVID-19: Spatial resolution of excess mortality in Germany and Italy.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30678.
    >> Share

  523. WELLBELOVE Z, Walsh C, Perinpanathan T, Lillie P, et al
    Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30673.
    >> Share

  524. DAHDOUH E, Lazaro-Perona F, Romero-Gomez MP, Mingorance J, et al
    Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.
    J Infect. 2020 Oct 24. pii: S0163-4453(20)30675.
    >> Share

  525. GANDINI O, Criniti A, Gagliardi MC, Ballesio L, et al
    Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients.
    J Infect. 2020 Oct 22. pii: S0163-4453(20)30654.
    >> Share

  526. MELE M, Henares D, Pino R, Asenjo S, et al
    Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.
    J Infect. 2020 Oct 21. pii: S0163-4453(20)30655.
    >> Share

  527. WELLS PM, Doores KJ, Couvreur S, Nunez RM, et al
    Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England.
    J Infect. 2020 Oct 14. pii: S0163-4453(20)30653.
    >> Share

  528. WALSH KA, Spillane S, Comber L, Cardwell K, et al
    The duration of infectiousness of individuals infected with SARS-CoV-2.
    J Infect. 2020 Oct 10. pii: S0163-4453(20)30651.
    >> Share

  529. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 pandemic on Measles surveillance in Pakistan.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30650.
    >> Share

  530. SONG W, Jia X, Zhang X, Ling Y, et al
    Co-infection in COVID-19, a cohort study.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30648.
    >> Share

  531. JIA X, Xiao L, Liu Y
    False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30649.
    >> Share

  532. BI J, Wang S, Wang Y, Yang D, et al
    Effect of Administering Subsequent Immune Checkpoint Inhibition in Cancer Patients with Prior COVID-19 Infection.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30647.
    >> Share

  533. MAO MH, Guo JJ, Qin LZ, Han ZX, et al
    Serial semiquantitative detection of SARS-CoV-2 in saliva samples.
    J Infect. 2020 Oct 5. pii: S0163-4453(20)30644.
    >> Share

  534. TANG JW, Kalliomaki P, Varila TM, Waris M, et al
    Nebulisers as a potential source of airborne virus.
    J Infect. 2020;81:647-679.
    >> Share

  535. GREEN ST, Cladi L
    High time for an efficient and effective internationally-supported Zoonosis Surveillance System?
    J Infect. 2020;81:647-679.
    >> Share

    September 2020
  536. DIMEGLIO C, Herin F, Miedouge M, Cambus JP, et al
    Screening for SARS-CoV-2 antibodies among healthcare workers in a University Hospital in Southern France.
    J Infect. 2020 Sep 30. pii: S0163-4453(20)30640.
    >> Share

  537. KUNDI H, Cetin EHO, Canpolat U, Aras S, et al
    The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19.
    J Infect. 2020 Sep 28. pii: S0163-4453(20)30636.
    >> Share

  538. SIXT T, Moretto F, Devilliers H, Abdallahoui M, et al
    The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30639.
    >> Share

  539. BRENDISH NJ, Poole S, Naidu VV, Mansbridge CT, et al
    Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30638.
    >> Share

  540. MOISEEV S, Brovko M, Tao E, Bulanov N, et al
    Sex differences in mortality in the intensive care unit patients with severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30635.
    >> Share

  541. HUANG W, Wu Q, Chen Z, Xiong Z, et al
    The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30632.
    >> Share

  542. MIYAZAWA DD
    Letter in response to article in journal of infection: "Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study".
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30637.
    >> Share

  543. SALTO-ALEJANDRE S, Roca-Oporto C, Martin-Gutierrez G, Aviles MD, et al
    A quick prediction tool for unfavourable outcome in COVID-19 inpatients:development and internal validation.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30619.
    >> Share

  544. SEATON RA, Gibbons CL, Cooper L, Malcolm W, et al
    Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    J Infect. 2020 Sep 25. pii: S0163-4453(20)30616.
    >> Share

  545. WANG S, Fu L, Huang K, Han J, et al
    Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019.
    J Infect. 2020 Sep 23. pii: S0163-4453(20)30630.
    >> Share

  546. PAGANI G, Conti F, Giacomelli A, Bernacchia D, et al
    Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30629.
    >> Share

  547. JUAN HC, Chao CM, Lai CC, Tang HJ, et al
    Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30624.
    >> Share

  548. PAN D, Sze S, Rogers B, Bron J, et al
    Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30623.
    >> Share

  549. KOW CS, Hasan SS
    The use of antimotility drugs in COVID-19 associated diarrhea.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30592.
    >> Share

  550. STANG A, Standl F, Kowall B, Brune B, et al
    Excess mortality due to COVID-19 in Germany.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30596.
    >> Share

  551. LI C, Zhang X, Zhu Y, Lin Q, et al
    Excess pneumonia and influenza death as herald wave of COVID-19 in England and Wales, United Kingdom.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30591.
    >> Share

  552. ORTH-HOLLER D, Eigentler A, Stiasny K, Weseslindtner L, et al
    Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30593.
    >> Share

  553. SORIANO MC, Vaquero C, Ortiz-Fernandez A, Caballero A, et al
    Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19.
    J Infect. 2020 Sep 18. pii: S0163-4453(20)30594.
    >> Share

  554. LADHANI SN, Chow JY, Atkin S, Brown KE, et al
    REGULAR MASS SCREENING FOR SARS-CoV-2 INFECTION IN CARE HOMES ALREADY AFFECTED BY COVID-19 OUTBREAKS: implications of false positive test results.
    J Infect. 2020 Sep 16. pii: S0163-4453(20)30621.
    >> Share

  555. GANDINI O, Criniti A, Ballesio L, Giglio S, et al
    Serum ferritin as an independent risk factor for acute respiratory distress syndrome in COVID-19 patients in Rome Italy.
    J Infect. 2020 Sep 15. pii: S0163-4453(20)30617.
    >> Share

  556. TANG HJ, Lai CC
    The association between corticosteroid uses and mortality among severe COVID-19 patients.
    J Infect. 2020 Sep 12. pii: S0163-4453(20)30599.
    >> Share

  557. ISHII M, Terai H, Kabata H, Masaki K, et al
    Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: a multicenter retrospective study.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30590.
    >> Share

  558. ELFIKY AA, Ibrahim IM, Ismail AM, Elshemey WM, et al
    A possible role for GRP78 in cross vaccination against COVID-19.
    J Infect. 2020 Sep 10. pii: S0163-4453(20)30598.
    >> Share

  559. RANA DMS, Usman MM, Alam DMM, Khalid DA, et al
    First trimester miscarriage in a pregnant woman infected with COVID-19 in Pakistan.
    J Infect. 2020 Sep 4. pii: S0163-4453(20)30587.
    >> Share

  560. BONGIOVANNI M, Zago T
    Acute hepatitis caused by asymptomatic COVID-19 infection.
    J Infect. 2020 Sep 3. pii: S0163-4453(20)30586.
    >> Share

  561. CHEN HJ, Lin HJ, Wu MC, Tang HJ, et al
    The implementation of an active surveillance integrating information technology and drive-through coronavirus testing station for suspected COVID-19 cases.
    J Infect. 2020 Sep 2. pii: S0163-4453(20)30585.
    >> Share

  562. BARNETT WR, Radhakrishnan M, Macko J, Hinch BT, et al
    Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: A retrospective study.
    J Infect. 2020 Sep 2. pii: S0163-4453(20)30583.
    >> Share

  563. MIRZA FN, Malik AA, Couzens C, Omer SB, et al
    Influenza-Negative Influenza-Like Illness (fnILI) Z-Score as a Proxy for Incidence and Mortality of COVID-19.
    J Infect. 2020 Sep 1. pii: S0163-4453(20)30581.
    >> Share

  564. KEVORKIAN JP, Riveline JP, Vandiedonck C, Girard D, et al
    Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study.
    J Infect. 2020 Sep 1. pii: S0163-4453(20)30579.
    >> Share

  565. HA DP, Van Krieken R, Carlos AJ, Lee AS, et al
    The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection.
    J Infect. 2020;81:452-482.
    >> Share

    August 2020
  566. AXELL-HOUSE DB, Lavingia R, Rafferty M, Clark E, et al
    The Estimation of Diagnostic Accuracy of Tests for COVID-19: A Scoping Review.
    J Infect. 2020 Aug 31. pii: S0163-4453(20)30577.
    >> Share

  567. YANYAN, Jiang X, Wang X, Liu B, et al
    CCL28 mucosal expression in SARS-CoV-2-infected patients with diarrhea in relation to disease severity.
    J Infect. 2020 Aug 29. pii: S0163-4453(20)30576.
    >> Share

  568. GRALL I, Alloui CA, Tandjaoui-Lambiotte Y, Deslandes A, et al
    Viral spreading in asymptomatic cases with SARS-CoV-2 infections: a Pilot study.
    J Infect. 2020 Aug 29. pii: S0163-4453(20)30578.
    >> Share

  569. KANAMORI H
    Rethinking environmental contamination and fomite transmission of SARS-CoV-2 in the healthcare.
    J Infect. 2020 Aug 27. pii: S0163-4453(20)30575.
    >> Share

  570. NSN G, C J, R M, P R, et al
    High rates of SARS-CoV-2 seropositivity in nursing home residents.
    J Infect. 2020 Aug 26. pii: S0163-4453(20)30574.
    >> Share

  571. LEI H, Xu X, Xiao S, Wu X, et al
    Household transmission of COVID-19-a systematic review and meta-analysis.
    J Infect. 2020 Aug 25. pii: S0163-4453(20)30571.
    >> Share

  572. DE LUSIGNAN S, Joy M, Oke J, McGagh D, et al
    Disparities in the excess risk of mortality in the first wave of COVID-19: cross sectional study of the English sentinel network.
    J Infect. 2020 Aug 25. pii: S0163-4453(20)30564.
    >> Share

  573. ARSHAD Y, Mahmood N, Zaidi SSZ, Sharif S, et al
    Detection of SARS-CoV-2 in ophthalmic secretions in Pakistan: A preliminary report.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30569.
    >> Share

  574. GARRIGUES E, Janvier P, Kherabi Y, Bot AL, et al
    Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30562.
    >> Share

  575. YAN Y, Liu B, Ding H, Wang X, et al
    Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30566.
    >> Share

  576. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30568.
    >> Share

  577. KROEMER M, Spehner L, Vettoretti L, Bouard A, et al
    COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30563.
    >> Share

  578. HE L, Zeng Y, Zeng C, Zhou Y, et al
    Positive Rate of Serology and RT-PCR for COVID-19 among Healthcare Workers during Different Periods in Wuhan, China.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30561.
    >> Share

  579. KORTE W, Buljan M, Rosslein M, Wick P, et al
    SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30567.
    >> Share

  580. LANDI F, Gremese E, Rota E, Carfi' A, et al
    Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30565.
    >> Share

  581. GROSSI E, Terruzzi V
    Exceptionally high COVID-19 viral load and very long duration of shedding in a young pauci-symptomatic child with autism resident in an Italian nursing home.
    J Infect. 2020 Aug 22. pii: S0163-4453(20)30560.
    >> Share

  582. LI Z, Xu H, Chen J, Pang Z, et al
    Internet-based remote consultation facilitates the medical care of patients with chronic skin diseases during COVID-19 pandemic.
    J Infect. 2020 Aug 21. pii: S0163-4453(20)30559.
    >> Share


  583. Clinical characteristics and outcome of COVID-19 pneumonia in elderly subjects.
    J Infect. 2020 Aug 19. pii: S0163-4453(20)30557.
    >> Share

  584. NAKAJIMA K, Abe T, Saji R, Ogawa F, et al
    Serum cholinesterase associated with COVID-19 pneumonia severity and mortality.
    J Infect. 2020 Aug 19. pii: S0163-4453(20)30555.
    >> Share

  585. BONGIOVANNI M, Vignati M, Giuliani G, Manes G, et al
    The dilemma of COVID-19 recurrence after clinical recovery.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30553.
    >> Share

  586. KELLENI MT
    SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30552.
    >> Share

  587. LIM RH, Chow A, Ho HJ
    Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30554.
    >> Share

  588. FAURY H, Courboules C, Payen M, Jary A, et al
    Medical Features of COVID-19 and Influenza Infection: A Comparative Study in Paris, France.
    J Infect. 2020 Aug 13. pii: S0163-4453(20)30551.
    >> Share

  589. TOMASSINI S, Kotecha D, Bird PW, Folwell A, et al
    Setting the criteria for SARS-CoV-2 reinfection - six possible cases.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30546.
    >> Share

  590. YUAN Y, Liu D, Zeng S, Wang S, et al
    In-hospital Use of ACEI/ARB is associated with lower Risk of Mortality and Critic Illness in COVID-19 Patients with Hypertension: ACEI/ARB protect COVID-19 patients.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30548.
    >> Share


  591. Previous cardiovascular surgery significantly increases the risk of developing critical illness in patients with COVID-19.
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30544.
    >> Share

  592. SADDIQUE A, Rana MS, Alam MM, Ikram A, et al
    "Emergence of co-infection of COVID-19 and dengue: A serious public health threat ".
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30545.
    >> Share

  593. LUIS GARCIA DE GUADIANAROMUALD, Mulero MDR, Olivo MH, Rojas CR, et al
    Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: a case series.
    J Infect. 2020 Aug 11. pii: S0163-4453(20)30543.
    >> Share

  594. KINOSHITA M, Tanaka M
    Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan.
    J Infect. 2020 Aug 11. pii: S0163-4453(20)30547.
    >> Share

  595. DAI CY, Dai TH, Ho HY, Ho CK, et al
    The strategies for the Coronavirus Disease 2019 (COVID-19) in Taiwan: A different tale.
    J Infect. 2020 Aug 10. pii: S0163-4453(20)30542.
    >> Share

  596. KIM YJ, Jeong YJ, Kim SH, Oh AR, et al
    Preparing for long-term non-face-to-face outpatient care services during the COVID-19 pandemic.
    J Infect. 2020 Aug 7. pii: S0163-4453(20)30540.
    >> Share

  597. AL-HATMI AMS, Mohsin J, Al-Huraizi A, Khamis F, et al
    COVID-19 associated invasive candidiasis.
    J Infect. 2020 Aug 6. pii: S0163-4453(20)30539.
    >> Share

  598. HAN J, Gong H, Fu L, Chen P, et al
    Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea.
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30536.
    >> Share

  599. BIRGAND G, Blanckaert K, Deschanvres C, Vaudron A, et al
    Testing strategies for the control of COVID-19 in nursing homes: Universal or targeted screening?
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30535.
    >> Share

  600. BOGLIONE L, Rostagno R, Poletti F, Moglia R, et al
    The proper use of corticosteroids for 2019-nCov pneumonia: towards promising results?
    J Infect. 2020 Aug 4. pii: S0163-4453(20)30534.
    >> Share

  601. WANG Y, Chow A
    Dancing with COVID-19 after the Hammer is Lifted: Enhancing Healthcare Worker Surveillance.
    J Infect. 2020 Aug 1. pii: S0163-4453(20)30533.
    >> Share

  602. LUI G, Ling L, Lai CK, Tso EY, et al
    Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  603. LUAN J, Lu Y, Gao S, Zhang L, et al
    A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2.
    J Infect. 2020;81:318-356.
    >> Share

  604. LIU Z, Long W, Tu M, Chen S, et al
    Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  605. XIE Y, Cao S, Dong H, Li Q, et al
    Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  606. FRONTERA A, Martin C, Vlachos K, Sgubin G, et al
    Regional air pollution persistence links to COVID-19 infection zoning.
    J Infect. 2020;81:318-356.
    >> Share

  607. XING Y, Ni W, Wu Q, Li W, et al
    Dynamics of faecal SARS-CoV-2 in infected children during the convalescent phase.
    J Infect. 2020;81:318-356.
    >> Share

  608. ZHANG Z, Shen Y, Wang H, Zhao L, et al
    High-resolution computed tomographic imaging disclosing COVID-19 pneumonia: A powerful tool in diagnosis.
    J Infect. 2020;81:318-356.
    >> Share

  609. LIU WD, Chang SY, Wang JT, Tsai MJ, et al
    Prolonged virus shedding even after seroconversion in a patient with COVID-19.
    J Infect. 2020;81:318-356.
    >> Share

  610. WANG L, Chen H, Qiu S, Song H, et al
    Evaluation of control measures for COVID-19 in Wuhan, China.
    J Infect. 2020;81:318-356.
    >> Share

  611. XIE H, Ying H
    Is the conclusion available? Letter to the Editor concerning the study of Prof. Jin titled "Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019".
    J Infect. 2020;81:e130-e131.
    >> Share

  612. ELKINGTON P, Morgan H
    Personal respirators for population level control of the COVID19 pandemic.
    J Infect. 2020;81:318-356.
    >> Share

    July 2020
  613. DE ABREU MC
    SARS-CoV-2 IgM and IgG rapid serologic test for the diagnosis of COVID-19 in the emergency department.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30513.
    >> Share

  614. CHETRIT A, Lechien JR, Ammar A, Chekkoury-Idrissi Y, et al
    Magnetic Resonance Imaging of COVID-19 Anosmic Patients Reveals Abnormalities of the Olfactory Bulb: Preliminary Prospective Study.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30509.
    >> Share

  615. HAMILTON F, Muir P, Attwood M, Vipond ANB, et al
    Kinetics and performance of the Abbott Architect SARS-CoV-2 IgG antibody assay.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30510.
    >> Share

  616. PALLETT SJC, Jones R, Pallett MA, Rayment M, et al
    Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30511.
    >> Share

  617. BLAIRON L, Mokrane S, Wilmet A, Dessilly G, et al
    Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30514.
    >> Share

  618. LADHANI SN, Chow JY, Janarthanan R, Fok J, et al
    INCREASED RISK OF SARS-CoV-2 INFECTION IN STAFF WORKING ACROSS DIFFERENT CARE HOMES ENCHANCED CoVID-19 OUTBREAK INVESTIGATIONS IN LONDON CARE HOMES.
    J Infect. 2020 Jul 28. pii: S0163-4453(20)30508.
    >> Share

  619. LU QB, Jiang WL, Zhang X, Li HJ, et al
    Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case-control study.
    J Infect. 2020 Jul 27. pii: S0163-4453(20)30507.
    >> Share

  620. WU J, Xie X, Yang L, Xu X, et al
    Mobile health technology combats Covid-19 in China.
    J Infect. 2020 Jul 27. pii: S0163-4453(20)30505.
    >> Share

  621. TU D, Shu J, Wu X, Li H, et al
    Immunological detection of serum antibodies in pediatric medical workers exposed to varying levels of SARS-CoV-2.
    J Infect. 2020 Jul 25. pii: S0163-4453(20)30504.
    >> Share

  622. BARNACLE JR, Cairney G, Rainsley J, Mercuri L, et al
    Changes in the hospital admission profile of COVID-19 positive patients at a central London trust.
    J Infect. 2020 Jul 23. pii: S0163-4453(20)30501.
    >> Share

  623. GIL E, Weller S, Rokadiya S, Mirfenderesky M, et al
    Letter in Response to 'Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown' Local Experience, National Questions. How Local is Local Enough?
    J Infect. 2020 Jul 23. pii: S0163-4453(20)30492.
    >> Share

  624. BI J, Lin Y, Zhong R, Jiang G, et al
    Prevalence and Clinical Characterization of Cancer Patients with Asymptomatic SARS-CoV-2 Infection History.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30493.
    >> Share

  625. VILLAR LM, da Costa VD, Marques BL, da Silva LL, et al
    USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30491.
    >> Share

  626. SHUAI H, Chu H, Hou Y, Yang D, et al
    Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: implications for treatment with IFN-beta and IFN inducer.
    J Infect. 2020 Jul 21. pii: S0163-4453(20)30490.
    >> Share

  627. FODJO JNS, Pengpid S, Villela EFM, Van TV, et al
    Mass masking as a way to contain COVID-19 and exit lockdown in low- and middle-income countries.
    J Infect. 2020 Jul 16. pii: S0163-4453(20)30489.
    >> Share

  628. LIU Q, Chen H, Zeng Q
    Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia.
    J Infect. 2020 Jul 11. pii: S0163-4453(20)30470.
    >> Share

  629. GROSSI E, Costantino L, Ferrara F, Terruzzi V, et al
    Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30469.
    >> Share


  630. Fasting blood glucose predicts the occurrence of critical illness in COVID-19 patients: a multicenter retrospective cohort study.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30464.
    >> Share

  631. ROKADIYA S, Gil E, Stubbs C, Bell D, et al
    COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30466.
    >> Share

  632. RAN J, Zhao S, Han L, Chen D, et al
    The Ambient Ozone and COVID-19 Transmissibility in China: A Data-Driven Ecological Study of 154 Cities.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30465.
    >> Share

  633. ROSSOTTI R, Travi G, Ughi N, Corradin M, et al
    SAFETY AND EFFICACY OF ANTI-IL6-RECEPTOR TOCILIZUMAB USE IN SEVERE AND CRITICAL PATIENTS AFFECTED BY CORONAVIRUS DISEASE 2019: A COMPARATIVE ANALYSIS.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30467.
    >> Share

  634. ZHA L, Shen J, Tefsen B, Wang Y, et al
    Clinical features and outcomes of adult COVID-19 patients co-infected with Mycoplasma pneumoniae.
    J Infect. 2020 Jul 8. pii: S0163-4453(20)30468.
    >> Share

  635. SALMON D, Bartier S, Hautefort C, Nguyen Y, et al
    Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter CORANOSMIA cohort study.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30463.
    >> Share

  636. KOMIYA K, Yamasue M, Takahashi O, Hiramatsu K, et al
    The COVID-19 pandemic and the true incidence of tuberculosis in Japan.
    J Infect. 2020 Jul 7. pii: S0163-4453(20)30462.
    >> Share

  637. LU L, Zhong W, Bian Z, Li Z, et al
    A Comparison of Mortality-related Risk Factors of COVID-19, SARS, and MERS: A Systematic Review and Meta-analysis.
    J Infect. 2020 Jul 4. pii: S0163-4453(20)30460.
    >> Share

  638. ARRIOLA-VILLALOBOS P, Fernandez-Perez C, Arino-Gutierrez M, Fernandez-Vigo JI, et al
    Letter in Response to Article in Journal of Infection: "High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients".
    J Infect. 2020 Jul 3. pii: S0163-4453(20)30459.
    >> Share

  639. CHANG CY, Chan KG
    Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.
    J Infect. 2020 Jul 3. pii: S0163-4453(20)30458.
    >> Share

  640. HUANG W, Lin D, Wang C, Bao C, et al
    The determination of release from isolation of COVID-19 patients requires ultra-high sensitivity nucleic acid test technology.
    J Infect. 2020 Jul 2. pii: S0163-4453(20)30456.
    >> Share

  641. YIN S, Tong X, Huang A, Shen H, et al
    Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
    J Infect. 2020 Jul 2. pii: S0163-4453(20)30457.
    >> Share

  642. XU B, Fan CY, Wang AL, Zou YL, et al
    Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    J Infect. 2020;81:e51-e60.
    >> Share

  643. TU H, Tu S, Gao S, Shao A, et al
    Current epidemiological and clinical features of COVID-19; a global perspective from China.
    J Infect. 2020;81:1-9.
    >> Share

  644. LIU Y, Du X, Chen J, Jin Y, et al
    Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
    J Infect. 2020;81:e6-e12.
    >> Share

  645. DU X, Yu X, Li Q, Li X, et al
    Duration for carrying SARS-CoV-2 in COVID-19 patients.
    J Infect. 2020;81:e78-e79.
    >> Share

  646. HE M, Xiong J, Huang S, Bian Y, et al
    Airborne precautions recommended in Wuhan, China for bedside fiberoptic bronchoscopy examination of patients with COVID-19.
    J Infect. 2020;81:e75-e77.
    >> Share

  647. ZUIN M, Rigatelli G, Zuliani G, Rigatelli A, et al
    Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis.
    J Infect. 2020;81:e84-e86.
    >> Share

  648. FANG X, Mei Q, Yang T, Li L, et al
    Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
    J Infect. 2020;81:147-178.
    >> Share

  649. BENVENUTO D, Angeletti S, Giovanetti M, Bianchi M, et al
    Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy.
    J Infect. 2020;81:e24-e27.
    >> Share

  650. YANG Z, Liu J, Zhou Y, Zhao X, et al
    The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
    J Infect. 2020;81:e13-e20.
    >> Share

  651. ZHU Z, Lu Z, Xu T, Chen C, et al
    Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
    J Infect. 2020;81:e21-e23.
    >> Share

  652. LU Y, Zhang L
    Social media WeChat infers the development trend of COVID-19.
    J Infect. 2020;81:e82-e83.
    >> Share

  653. PAN Y, Li X, Yang G, Fan J, et al
    Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients.
    J Infect. 2020;81:e28-e32.
    >> Share

  654. ZENG Z, Chen L, Pan Y, Deng Q, et al
    Re: Profile of specific antibodies to SARS-CoV-2: The first report.
    J Infect. 2020;81:e80-e81.
    >> Share

  655. WANG Z, Ma W, Zheng X, Wu G, et al
    Household transmission of SARS-CoV-2.
    J Infect. 2020;81:179-182.
    >> Share

  656. LIU L, Quan J, Lv J, Long S, et al
    A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
    J Infect. 2020;81:147-178.
    >> Share

  657. SHEN L, Li S, Zhu Y, Zhao J, et al
    Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China.
    J Infect. 2020;81:147-178.
    >> Share

  658. ZHOU J, Tan Y, Li D, He X, et al
    Observation and analysis of 26 cases of asymptomatic SARS-COV2 infection.
    J Infect. 2020;81:e69-e70.
    >> Share

    June 2020
  659. LIM KH, Yang S, Kim SH, Joo JY, et al
    Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30453.
    >> Share

  660. BATISSE D, Benech N, Botelho-Nevers E, Bouiller K, et al
    Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30454.
    >> Share

  661. GIANNIS D, Ziogas IA
    Letter in response to article in journal of infection: "Cardiovascular complications in COVID-19: A systematic review and meta-analysis".
    J Infect. 2020 Jun 30. pii: S0163-4453(20)30455.
    >> Share

  662. VRSALOVIC M, Presecki AV
    Cardiac injury and mortality in COVID-19: a reappraisal.
    J Infect. 2020 Jun 29. pii: S0163-4453(20)30447.
    >> Share

  663. WALSH KA, Jordan K, Clyne B, Rohde D, et al
    SARS-CoV-2 Detection, Viral Load and Infectivity over the Course of an Infection: SARS-CoV-2 Detection, Viral Load and Infectivity.
    J Infect. 2020 Jun 29. pii: S0163-4453(20)30449.
    >> Share

  664. BROWN C, Clare K, Chand M, Andrews J, et al
    Snapshot PCR Surveillance for SARS-CoV-2 in Hospital Staff in England.
    J Infect. 2020 Jun 29. pii: S0163-4453(20)30450.
    >> Share

  665. KUMAR DR, Bhattacharya DB, Meena DV, Soneja DM, et al
    COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity' or 'death'.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30443.
    >> Share

  666. PIASERICO S, Meneguzzo A, Messina F
    REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30444.
    >> Share

  667. PRAZUCK T, Giache S, Gubavu C, Colin M, et al
    Investigation of a family outbreak of COVID-19 using systematic rapid diagnostic tests raises new questions about transmission.
    J Infect. 2020 Jun 28. pii: S0163-4453(20)30448.
    >> Share

  668. T U, Jc H, Ar H, Ke M, et al
    Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure.
    J Infect. 2020 Jun 27. pii: S0163-4453(20)30442.
    >> Share

  669. ZHU J, Guo J, Xu Y, Chen X, et al
    Viral dynamics of SARS-CoV-2 in saliva from infected patients.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30440.
    >> Share

  670. DE DEYN MLZQ, Ng QX, Loke W, Yeo WS, et al
    A tale of two cities: a comparison of Hong Kong and Singapore's early strategies for the Coronavirus Disease 2019 (COVID-19).
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30439.
    >> Share

  671. MOYNAN D, Cagney M, Dhuthaigh AN, Foley M, et al
    The role of healthcare staff COVID-19 screening in infection prevention & control.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30438.
    >> Share

  672. LIANG X, Shi L, Wang Y, Xiao W, et al
    The association of hypertension with the severity and mortality of COVID-19 patients: evidence based on adjusted effect estimates.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30441.
    >> Share

  673. YOUNGS J, Wyncoll D, Hopkins P, Arnold A, et al
    Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza.
    J Infect. 2020 Jun 25. pii: S0163-4453(20)30436.
    >> Share

  674. LIN Z, Long F, Yang Y, Chen X, et al
    Serum ferritin as an independent risk factor for severity in COVID-19 patients.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30434.
    >> Share

  675. BOUZA E, Perez-Granda MJ, Escribano P, Fernandez-Del Rey R, et al
    OUTBREAK OF COVID-19 IN A NURSING HOME IN MADRID.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30437.
    >> Share

  676. CANTINI F, Niccoli L, Nannini C, Matarrese D, et al
    Retrospective, multicenter study on the impact of baricitinib in COVID-19 moderate pneumonia.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30433.
    >> Share

  677. OTTE MS, Klussmann JP, Luers JC
    Persisting olfactory dysfunction in patients after recovering from COVID-19.
    J Infect. 2020 Jun 24. pii: S0163-4453(20)30435.
    >> Share

  678. JARY A, Flandre P, Chabouis A, Nguyen S, et al
    Clinical presentation of Covid-19 in health care workers from a French University Hospital.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30424.
    >> Share

  679. FAN J, Li X, Gao Y, Zhou J, et al
    The Lung Tissue Microbiota Features of 20 Deceased Patients with COVID-19.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30429.
    >> Share

  680. FIORE A, de Roux Q, Daami N, Clariot S, et al
    Clinical feedback from experience with COVID-19: specific considerations for ExtraCorporeal Membrane Oxygenation.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30431.
    >> Share

  681. HATTORI T, Amishima M, Morinaga D, Kamada K, et al
    Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30428.
    >> Share

  682. AZZI L, Baj A, Alberio T, Lualdi M, et al
    RAPID SALIVARY TEST SUITABLE FOR A MASS SCREENING PROGRAM TO DETECT SARS-COV-2: A DIAGNOSTIC ACCURACY STUDY.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30423.
    >> Share

  683. SKEVAKI C, Fragkou PC, Cheng C, Xie M, et al
    Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30420.
    >> Share

  684. M MB, L B, I A, P D, et al
    Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients: Etoposide for severe COVID-19 patients.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30386.
    >> Share

  685. KUNUTSOR SK, Laukkanen JA
    Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30425.
    >> Share

  686. CLARK TW, Brendish NJ, Poole S, Naidu VV, et al
    Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30432.
    >> Share

  687. CHEN J, Huang C, Zhang Y, Zhang S, et al
    Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Pets in Wuhan, China.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30427.
    >> Share

  688. WONG M, Huang J, Teoh J, Wong S, et al
    Evaluation on different non-pharmaceutical interventions during COVID-19 pandemic: an analysis of 139 countries.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30426.
    >> Share

  689. DAUNT A, Perez-Guzman PN, Liew F, Hauck K, et al
    Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir use in patients with COVID-19 disease.
    J Infect. 2020 Jun 21. pii: S0163-4453(20)30430.
    >> Share

  690. CENTO V, Colagrossi L, Nava A, Lamberti A, et al
    Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients.
    J Infect. 2020 Jun 20. pii: S0163-4453(20)30405.
    >> Share

  691. ZHANG H, Wu T
    CD4+T, CD8+T counts and severe COVID-19: A meta-analysis.
    J Infect. 2020 Jun 19. pii: S0163-4453(20)30417.
    >> Share

  692. AZOULAY D, Shehadeh M, Chepa S, Shaoul E, et al
    Recovery from SARS-CoV-2 infection is Associated with Serum BDNF Restoration.
    J Infect. 2020 Jun 19. pii: S0163-4453(20)30419.
    >> Share

  693. MCDEVITT KEM, Ganjoo N, Mlangeni D, Pathak S, et al
    Outcome of Universal screening of asymptomatic neonates for COVID-19 from asymptomatic mothers.
    J Infect. 2020 Jun 18. pii: S0163-4453(20)30418.
    >> Share

  694. VAN TAN L, Hong NTT, Ngoc NM, Thanh TT, et al
    SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30410.
    >> Share

  695. LIU F, Long X, Ji G, Zhang B, et al
    Clinically significant portal hypertension in cirrhosis patients with COVID-19: clinical characteristics and outcomes.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30409.
    >> Share

  696. KHALIL K, Agbontaen K, McNally D, Love A, et al
    Clinical Characteristics and 28-Day Mortality of Medical Patients Admitted with COVID-19 to a Central London Teaching Hospital.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30408.
    >> Share

  697. BIRD P, Badhwar V, Fallon K, Kwok KO, et al
    High SARS-CoV-2 infection rates in respiratory staff nurses and correlation of COVID-19 symptom patterns with PCR positivity and relative viral loads.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30415.
    >> Share

  698. KOLLIAS A, Kyriakoulis KG, Destounis A, Stergiou GS, et al
    Letter to the EditorCARDIAC INJURY AND PROGNOSIS IN COVID-19: METHODOLOGICAL CONSIDERATIONS AND UPDATED META-ANALYSIS.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30413.
    >> Share

  699. CHEN F, Fu D, Yang Q, Geng Z, et al
    Low Transmission Risk of 9 Asymptomatic Carriers Tested Positive for both SARS-CoV-2 Nucleic Acid and Serum IgG.
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30416.
    >> Share

  700. KRUPP KF, Madhivanan P, Perez-Velez CM
    Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients?
    J Infect. 2020 Jun 17. pii: S0163-4453(20)30411.
    >> Share

  701. WU JL, Tseng WP, Lin CH, Lee TF, et al
    Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    J Infect. 2020 Jun 15. pii: S0163-4453(20)30404.
    >> Share

  702. TOMB RM, MacLean DAR, Gunson PRN
    Retrospective screening for SARS-CoV-2 in Greater Glasgow and Clyde ICUs between December 2019 and February 2020.
    J Infect. 2020 Jun 15. pii: S0163-4453(20)30403.
    >> Share

  703. MARKO C, Andro K, Danijela C
    Math and aftermath of COVID-19 pandemic and its interrelationship from the resilience perspective.
    J Infect. 2020 Jun 13. pii: S0163-4453(20)30401.
    >> Share

  704. YU J, Yang Z, Zhou X, Wu D, et al
    Prognostic value of Carcinoembryonic antigen on outcome in patients with Coronavirus disease 2019.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30399.
    >> Share

  705. THIJSEN S, Heron M, Gremmels H, van der Kieft R, et al
    Elevated nucleoprotein-induced interferon-gamma release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assay.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30395.
    >> Share

  706. DARAEI H, Toolabian K, Kazempour M, Javanbakht M, et al
    The role of the environment and its pollution in the prevalence of COVID-19.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30400.
    >> Share

  707. JUNG J, Kim JY, Bae S, Cha HH, et al
    Contamination of personal protective equipment by SARS-CoV-2 during routine care of patients with mild COVID-19.
    J Infect. 2020 Jun 12. pii: S0163-4453(20)30402.
    >> Share

  708. WONG MC, Huang J, Lai C, Ng R, et al
    Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis.
    J Infect. 2020 Jun 11. pii: S0163-4453(20)30394.
    >> Share

  709. GALLO O, Giovanni LL, Orlando P, Martelli F, et al
    "Is really the cancer population at risk for more severe COVID-19? Some hints from the cytokine profile".
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30392.
    >> Share

  710. ROSAKIS P, Marketou ME
    Rethinking case fatality ratios for covid-19 from a data-driven viewpoint.
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30391.
    >> Share

  711. LAI CC, Yu WL
    The COVID-19 Pandemic and Tuberculosis in Taiwan.
    J Infect. 2020 Jun 10. pii: S0163-4453(20)30397.
    >> Share

  712. GRIFONI E, Valoriani A, Cei F, Lamanna R, et al
    Interleukin-6 as prognosticator in patients with COVID-19: IL-6 and Covid-19.
    J Infect. 2020 Jun 8. pii: S0163-4453(20)30388.
    >> Share

  713. LI G
    Aspartate aminotransferase: a prognostic marker rather than a specific liver injury marker in COVID-19.
    J Infect. 2020 Jun 7. pii: S0163-4453(20)30389.
    >> Share

  714. FURUSE Y, Oshitani H
    Association between Numbers of "Imported Cases" and "Reported Cases in a Source Country" of COVID-19: January to April 2020 in Japan.
    J Infect. 2020 Jun 6. pii: S0163-4453(20)30383.
    >> Share

  715. BUETTI N, Mazzuchelli T, Priore EL, Balmelli C, et al
    Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
    J Infect. 2020 Jun 5. pii: S0163-4453(20)30381.
    >> Share

  716. YOU J, Zhang L, Ni-Jia-Ti MY, Zhang J, et al
    Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge: a prospective cohort study.
    J Infect. 2020 Jun 5. pii: S0163-4453(20)30382.
    >> Share

  717. ZHU C, Liu W, Su H, Li S, et al
    nBreastfeeding Risk from Detectable Severe Acute Respiratory Syndrome Coronavirus 2 in Breastmilk.
    J Infect. 2020 Jun 4. pii: S0163-4453(20)30379.
    >> Share

  718. CHEN Y, Tong X, Wang J, Huang W, et al
    High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.
    J Infect. 2020 Jun 4. pii: S0163-4453(20)30344.
    >> Share

  719. IWASAKI S, Fujisawa S, Nakakubo S, Kamada K, et al
    Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
    J Infect. 2020 Jun 4. pii: S0163-4453(20)30349.
    >> Share

  720. KRATZEL A, Steiner S, Todt D, V'kovski P, et al
    Temperature-dependent surface stability of SARS-CoV-2.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30352.
    >> Share

  721. KUNUTSOR SK, Laukkanen JA
    Cardiovascular complications in COVID-19: A systematic review and meta-analysis.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30345.
    >> Share

  722. GUEMES-VILLAHOZ N, Burgos-Blasco B, Arribi-Vilela A, Arriola-Villalobos P, et al
    SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30346.
    >> Share

  723. GRAHAM N, Junghans C, Downes R, Sendall C, et al
    SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30348.
    >> Share

  724. RAZANAMAHERY J, Soumagne T, Humbert S, Brunel AS, et al
    Does type of immunosupression influence the course of Covid-19 infection?
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30351.
    >> Share

  725. MENDOZA VMM
    Interleukin-17: a potential therapeutic target in COVID-19.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30350.
    >> Share

  726. HE B, Zhong A, Wu Q, Liu X, et al
    Tumor biomarkers predict clinical outcome of COVID-19 patients.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30347.
    >> Share

  727. TUAILLON E, Bollore K, Pisoni A, Debiesse S, et al
    Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
    J Infect. 2020 Jun 3. pii: S0163-4453(20)30376.
    >> Share

  728. LIU M, Gao Y, Zhang Y, Shi S, et al
    The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis.
    J Infect. 2020 Jun 2. pii: S0163-4453(20)30342.
    >> Share

  729. HUANG L, Zhang X, Zhang X, Wei Z, et al
    Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing stud
    J Infect. 2020;80:e1-e13.
    >> Share

  730. FU L, Wang B, Yuan T, Chen X, et al
    Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.
    J Infect. 2020;80:656-665.
    >> Share

  731. YE Q, Wang B, Mao J
    The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
    J Infect. 2020;80:607-613.
    >> Share

  732. YANG P, Liu P, Li D, Zhao D, et al
    Corona Virus Disease 2019, a growing threat to children?
    J Infect. 2020;80:671-693.
    >> Share

  733. SUN H, Lu M, Chen S, Cheng Z, et al
    Nosocomial SARS-CoV-2 infection among nurses in Wuhan at a single centre.
    J Infect. 2020;80:e41-e42.
    >> Share

  734. CHEN L, Cai J, Lin Q, Xiang B, et al
    Imported COVID-19 cases pose new challenges for China.
    J Infect. 2020;80:e43-e44.
    >> Share

  735. ZHANG J, Jia W, Zhu J, Li B, et al
    Insights into the cross-species evolution of 2019 novel coronavirus.
    J Infect. 2020;80:671-693.
    >> Share

  736. HAO W, Li M
    Clinical features of atypical 2019 novel coronavirus pneumonia with an initially negative RT-PCR assay.
    J Infect. 2020;80:671-693.
    >> Share

  737. GAO Y, Shi C, Chen Y, Shi P, et al
    A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China.
    J Infect. 2020;80:666-670.
    >> Share

    May 2020
  738. GALLOWAY JB, Norton S, Barker RD, Brookes A, et al
    A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study.
    J Infect. 2020 May 29. pii: S0163-4453(20)30314.
    >> Share

  739. SZE S, Pan D, Williams CML, Wong N, et al
    Letter to the Editor: Variability but not admission or trends in NEWS2 score predicts clinical outcome in elderly hospitalised patients with COVID-19.
    J Infect. 2020 May 29. pii: S0163-4453(20)30341.
    >> Share

  740. LIU M, Gao Y, Shi S, Chen Y, et al
    Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30320.
    >> Share

  741. ZHENG X, Wang H, Su Z, Li W, et al
    Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China.
    J Infect. 2020 May 28. pii: S0163-4453(20)30319.
    >> Share

  742. WU P, Lu W, He L, Meng Y, et al
    COVID-19 Patients with Recent Influenza A/B Infection: A Retrospective Study.
    J Infect. 2020 May 28. pii: S0163-4453(20)30333.
    >> Share

  743. PIROLA CJ, Sookoian S
    Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30329.
    >> Share

  744. AFSHAR ZM, Dayani M, Naderi M, Ghabarveisi F, et al
    Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30340.
    >> Share

  745. MOISEEV S, Avdeev S, Brovko M, Akulkina L, et al
    Cancer in intensive care unit patients with COVID-19.
    J Infect. 2020 May 28. pii: S0163-4453(20)30327.
    >> Share

  746. WONG MC, Teoh JY, Huang J, Wong SH, et al
    The potential impact of vulnerability and coping capacity on the pandemic control of COVID-19.
    J Infect. 2020 May 28. pii: S0163-4453(20)30337.
    >> Share

  747. NGUYEN Y, Corre F, Honsel V, Curac S, et al
    Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.
    J Infect. 2020 May 28. pii: S0163-4453(20)30330.
    >> Share

  748. MEYLAN S, Akrour R, Regina J, Bart PA, et al
    An Early Warning Score to predict ICU admission in COVID-19 positive patients.
    J Infect. 2020 May 28. pii: S0163-4453(20)30324.
    >> Share

  749. COLTON H, Ankcorn M, Yavuz M, Tovey L, et al
    Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.
    J Infect. 2020 May 28. pii: S0163-4453(20)30339.
    >> Share

  750. BETTENCOURT P, Fernandes C, Gil A, Almeida A, et al
    Qualitative serology in patients recovered from SARS CoV 2 infection.
    J Infect. 2020 May 28. pii: S0163-4453(20)30335.
    >> Share

  751. ZHONG Y, Wang K, Zhu Y, Lyu D, et al
    COVID-19: Evidence of the Eye.
    J Infect. 2020 May 28. pii: S0163-4453(20)30331.
    >> Share

  752. SAGNELLI C, Gentile V, Tirri R, Macera M, et al
    Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient.
    J Infect. 2020 May 28. pii: S0163-4453(20)30322.
    >> Share

  753. KUNUTSOR SK, Laukkanen JA
    Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.
    J Infect. 2020 May 28. pii: S0163-4453(20)30325.
    >> Share

  754. HU J, Zhang X, Zhang X, Zhao H, et al
    COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome.
    J Infect. 2020 May 28. pii: S0163-4453(20)30334.
    >> Share

  755. PENG HC, Hussin N, Nalliah S, Ooi WT, et al
    Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
    J Infect. 2020 May 28. pii: S0163-4453(20)30336.
    >> Share

  756. KAKKAR DN, Dunphy DJ, Raza DM
    Ethnicity profiles of COVID-19 admissions and outcomes.
    J Infect. 2020 May 27. pii: S0163-4453(20)30338.
    >> Share

  757. LANSBURY L, Lim B, Baskaran V, Lim WS, et al
    Co-infections in people with COVID-19: a systematic review and meta-analysis.
    J Infect. 2020 May 27. pii: S0163-4453(20)30323.
    >> Share

  758. BORGHETTI A, Ciccullo A, Paratore M, Rovedi F, et al
    Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.
    J Infect. 2020 May 27. pii: S0163-4453(20)30321.
    >> Share

  759. WONG MC, Teoh JY, Huang J, Wong SH, et al
    Strengthening early testing and surveillance of COVID-19 to enhance identification of asymptomatic patients.
    J Infect. 2020 May 27. pii: S0163-4453(20)30328.
    >> Share

  760. VARIKASUVU SR, Dutt N
    Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot.
    J Infect. 2020 May 27. pii: S0163-4453(20)30316.
    >> Share

  761. KLEMENT-FRUTOS E, Burrel S, Peytavin G, Marot S, et al
    Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
    J Infect. 2020 May 27. pii: S0163-4453(20)30318.
    >> Share


  762. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19.
    J Infect. 2020 May 27. pii: S0163-4453(20)30317.
    >> Share

  763. GOSCE L, Phillips PA, Spinola P, Gupta DRK, et al
    Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown.
    J Infect. 2020 May 24. pii: S0163-4453(20)30315.
    >> Share

  764. FRONTERA A, Cianfanelli L, Vlachos K, Landoni G, et al
    Severe air pollution links to higher mortality in COVID-19 patients: the "double-hit" hypothesis.
    J Infect. 2020 May 21. pii: S0163-4453(20)30285.
    >> Share

  765. NOH JY, Yoon JG, Seong H, Choi WS, et al
    Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration.
    J Infect. 2020 May 21. pii: S0163-4453(20)30310.
    >> Share

  766. DE SOUZA LUNA LK, Perosa DAH, Conte DD, Carvalho JMA, et al
    Different patterns of Influenza A and B detected during early stages of COVID-19 in a university hospital in Sao Paulo, Brazil.
    J Infect. 2020 May 21. pii: S0163-4453(20)30313.
    >> Share

  767. MANZONI P, Milillo C
    Covid-19 mortality in Italian Doctors.
    J Infect. 2020 May 20. pii: S0163-4453(20)30311.
    >> Share

  768. ANIM DO, Ofori-Asenso R
    Water scarcity and COVID-19 in sub-Saharan Africa.
    J Infect. 2020 May 20. pii: S0163-4453(20)30312.
    >> Share

  769. TANG JW, Young S, May S, Bird P, et al
    Comparing hospitalised, community and staff COVID-19 infection rates during the early phase of the evolving COVID-19 epidemic.
    J Infect. 2020 May 19. pii: S0163-4453(20)30308.
    >> Share

  770. CAI C, Ahmed OA, Shen H, Zeng S, et al
    Which cancer type has the highest risk of COVID-19 infection?
    J Infect. 2020 May 19. pii: S0163-4453(20)30307.
    >> Share

  771. VOINSKY I, Baristaite G, Gurwitz D
    Effects of age and sex on recovery from COVID-19: Analysis of 5,769 Israeli patients.
    J Infect. 2020 May 16. pii: S0163-4453(20)30303.
    >> Share

  772. CHEN DX, Shan Y
    Mesenchymal stem cell therapy in severe COVID-19: a retrospective study of short-term treatment efficacy and side effects.
    J Infect. 2020 May 15. pii: S0163-4453(20)30295.
    >> Share

  773. SHI L, Wang Y, Wang Y, Duan G, et al
    Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.
    J Infect. 2020 May 14. pii: S0163-4453(20)30288.
    >> Share

  774. BRUNO G, Perelli S, Fabrizio C, Buccoliero GB, et al
    Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an Infectious Diseases Unit in Southern Italy.
    J Infect. 2020 May 14. pii: S0163-4453(20)30301.
    >> Share

  775. GOURSAUD S, Descamps R, Daubin C, du Cheyron D, et al
    Corticosteroid use in selected patients with severe Acute Respiratory Distress Syndrome related to Covid-19.
    J Infect. 2020 May 14. pii: S0163-4453(20)30299.
    >> Share

  776. HUANG W, Zhao Z, He Z, Liu S, et al
    Unfavorable outcomes in pregnant patients with COVID-19 outside Wuhan, China.
    J Infect. 2020 May 14. pii: S0163-4453(20)30292.
    >> Share

  777. MARIE TH, Laurent B, Alain W, Ingrid B, et al
    The role of serology for COVID-19 control: Population, kinetics and test performance do matter.
    J Infect. 2020 May 14. pii: S0163-4453(20)30297.
    >> Share

  778. JIA Y, Yang C, Zhang M, Yang X, et al
    Characterization of eight novel full-length genomes of SARS-CoV-2 among imported COVID-19 cases from abroad in Yunnan, China.
    J Infect. 2020 May 14. pii: S0163-4453(20)30291.
    >> Share

  779. GAO Y, Chen Y, Liu M, Shi S, et al
    Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis.
    J Infect. 2020 May 14. pii: S0163-4453(20)30294.
    >> Share

  780. TUNESI S, Bourgarit A
    Prescribing COVID-19 treatments: what we should never forget.
    J Infect. 2020 May 13. pii: S0163-4453(20)30298.
    >> Share

  781. CHEN L, Zhang B, Ti MN, Yang K, et al
    Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): a comparative study.
    J Infect. 2020 May 13. pii: S0163-4453(20)30296.
    >> Share

  782. VRSALOVIC M, Vrsalovic Presecki A
    Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates.
    J Infect. 2020 May 13. pii: S0163-4453(20)30300.
    >> Share

  783. WOODRUFF A
    COVID-19 Follow up Testing.
    J Infect. 2020 May 11. pii: S0163-4453(20)30289.
    >> Share

  784. PIROLA CJ, Sookoian S
    Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.
    J Infect. 2020 May 11. pii: S0163-4453(20)30284.
    >> Share

  785. JAYARAJ R
    Clinical and conceptual comments on "Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis".
    J Infect. 2020 May 11. pii: S0163-4453(20)30287.
    >> Share

  786. AITKEN T, Chin KL, Liew D, Ofori-Asenso R, et al
    Rethinking pandemic preparation: Global Health Security Index (GHSI) is predictive of COVID-19 burden, but in the opposite direction.
    J Infect. 2020 May 8. pii: S0163-4453(20)30273.
    >> Share

  787. LEE J, Lee YH, Chang HH, Choi SH, et al
    Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system.
    J Infect. 2020 May 8. pii: S0163-4453(20)30278.
    >> Share

  788. JUNG J, Oh DK, Ahn JH, Hong SB, et al
    Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
    J Infect. 2020 May 8. pii: S0163-4453(20)30277.
    >> Share

  789. NG JJ, Luo Y, Phua K, Choong AMTL, et al
    Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis.
    J Infect. 2020 May 8. pii: S0163-4453(20)30280.
    >> Share

  790. RAVIOLI S, Ochsner H, Lindner G
    Reactivation of COVID-19 pneumonia: A report of two cases.
    J Infect. 2020 May 7. pii: S0163-4453(20)30279.
    >> Share

  791. SU Y, Tu GW, Ju MJ, Yu SJ, et al
    Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19.
    J Infect. 2020 May 7. pii: S0163-4453(20)30281.
    >> Share

  792. DEMEY B, Daher N, Francois C, Lanoix JP, et al
    Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
    J Infect. 2020 May 7. pii: S0163-4453(20)30244.
    >> Share

  793. ZHANG B, Liu S, Zhang J, Xiao J, et al
    Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study.
    J Infect. 2020 May 7. pii: S0163-4453(20)30272.
    >> Share

  794. AYLWIN SJ, Patel AS, Post FA
    COVID-19 diagnoses in South East London peaked before the UK suggesting early measures reduced transmission.
    J Infect. 2020 May 3. pii: S0163-4453(20)30269.
    >> Share

  795. CHIN KL, Ofori-Asenso R, Jordan KA, Jones D, et al
    Early signs that COVID-19 is being contained in Australia.
    J Infect. 2020 May 1. pii: S0163-4453(20)30268.
    >> Share

  796. ZHANG Z, Xiao K, Zhang X, Roy A, et al
    Emergence of SARS-like coronavirus in China: An update.
    J Infect. 2020;80:e28-e29.
    >> Share

  797. WANG D, Zhou M, Nie X, Qiu W, et al
    Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China.
    J Infect. 2020;80:e25-e27.
    >> Share

    April 2020
  798. MENG Y, Guo E, Liu J, Huang X, et al
    Value and Challenges: Nucleic Acid Amplification Tests for SARS-CoV-2 in Hospitalized COVID-19 Patients.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30261.
    >> Share

  799. YE G, Lin H, Chen L, Wang S, et al
    Environmental Contamination of SARS-CoV-2 in Healthcare Premises.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30260.
    >> Share

  800. CHOW A, Hein AA, Kyaw WM
    Unintended Consequence: Influenza plunges with public health response to COVID-19 in Singapore.
    J Infect. 2020 Apr 30. pii: S0163-4453(20)30262.
    >> Share

  801. LIU Y, Lam TTY, Lai FYL, Krajden M, et al
    Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions.
    J Infect. 2020 Apr 29. pii: S0163-4453(20)30243.
    >> Share

  802. DIMEGLIO C, Loubes JM, Deporte B, Dubois M, et al
    The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.
    J Infect. 2020 Apr 29. pii: S0163-4453(20)30242.
    >> Share

  803. ZHEN-DONG Y, Gao-Jun Z, Run-Ming J, Zhi-Sheng L, et al
    Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: A review.
    J Infect. 2020 Apr 28. pii: S0163-4453(20)30241.
    >> Share

  804. CHU Y, Li T, Fang Q, Wang X, et al
    Clinical features of critically ill patients with confirmed COVID-19.
    J Infect. 2020 Apr 28. pii: S0163-4453(20)30150.
    >> Share

  805. TOMLINS J, Hamilton F, Gunning S, Sheehy C, et al
    Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort.
    J Infect. 2020 Apr 27. pii: S0163-4453(20)30232.
    >> Share

  806. PETERS A, Lotfinejad N, Simniceanu A, Pittet D, et al
    The economics of infection prevention: why it is crucial to invest in hand hygiene and nurses during the novel coronavirus pandemic.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30240.
    >> Share

  807. ZHANG B, Liu S, Dong Y, Zhang L, et al
    Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19).
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30233.
    >> Share

  808. SPICUZZA L, Montineri A, Manuele R, Crimi C, et al
    Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: a preliminary report.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30231.
    >> Share

  809. WU J, Liang J, Zhou H, Peng F, et al
    Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30238.
    >> Share

  810. MINOTTI C, Tirelli F, Barbieri E, Giaquinto C, et al
    How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30237.
    >> Share

  811. SONG R, Han B, Song M, Wang L, et al
    Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30229.
    >> Share

  812. JIANG Y, Niu W, Wang Q, Zhao H, et al
    Characteristics of a family cluster of Severe Acute Respiratory Syndrome Coronavirus 2 in Henan, China.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30239.
    >> Share

  813. ZHENG Z, Peng F, Xu B, Zhao J, et al
    Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30234.
    >> Share

  814. LEE YL, Liao CH, Liu PY, Cheng CY, et al
    Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30230.
    >> Share

  815. CHENG VCC, Wong SC, Chuang VWM, So SYC, et al
    The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2.
    J Infect. 2020 Apr 23. pii: S0163-4453(20)30235.
    >> Share

  816. CANTINI F, Niccoli L, Matarrese D, Nicastri E, et al
    Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.
    J Infect. 2020 Apr 22. pii: S0163-4453(20)30228.
    >> Share

  817. LI J, Li Z, Cui X, Wu C, et al
    Bayesian phylodynamic inference on the temporal evolution and global transmission of SARS-CoV-2.
    J Infect. 2020 Apr 20. pii: S0163-4453(20)30227.
    >> Share

  818. LI H, Chen K, Liu M, Xu H, et al
    The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia.
    J Infect. 2020 Apr 20. pii: S0163-4453(20)30207.
    >> Share

  819. LIU X, Zhou H, Zhou Y, Wu X, et al
    Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30216.
    >> Share

  820. GODAERT L, Proye E, Demoustier-Tampere D, Coulibaly PS, et al
    Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30217.
    >> Share

  821. KENYON C
    Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30215.
    >> Share

  822. WEI YY, Wang RR, Zhang DW, Tu YH, et al
    Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China.
    J Infect. 2020 Apr 16. pii: S0163-4453(20)30219.
    >> Share

  823. LV B, Li Z, Chen Y, Long C, et al
    Global COVID-19 fatality analysis reveals Hubei-like countries potentially with severe outbreaks.
    J Infect. 2020 Apr 14. pii: S0163-4453(20)30157.
    >> Share

  824. MA J, Yin J, Qian Y, Wu Y, et al
    Clinical Characteristics and Prognosis in Cancer Patients with COVID-19: a Single Center's Retrospective Study.
    J Infect. 2020 Apr 13. pii: S0163-4453(20)30214.
    >> Share

  825. AZZI L, Carcano G, Gianfagna F, Grossi P, et al
    SALIVA IS A RELIABLE TOOL TO DETECT SARS-CoV-2.
    J Infect. 2020 Apr 13. pii: S0163-4453(20)30213.
    >> Share

  826. MENG H, Xiong R, He R, Lin W, et al
    CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China.
    J Infect. 2020 Apr 12. pii: S0163-4453(20)30211.
    >> Share

  827. YANG H, Sun G, Tang F, Peng M, et al
    Clinical Features and Outcomes of Pregnant Women Suspected of Coronavirus Disease 2019.
    J Infect. 2020 Apr 12. pii: S0163-4453(20)30212.
    >> Share

  828. JIANG DM
    Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19).
    J Infect. 2020 Apr 11. pii: S0163-4453(20)30152.
    >> Share

  829. ZHANG X, Chen X, Zhang Z, Roy A, et al
    Strategies to trace back the origin of COVID-19.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30160.
    >> Share

  830. WANG JT, Lin YY, Chang SY, Yeh SH, et al
    The Role of Phylogenetic Analysis in Clarifying the Infection Source of a COVID-19 Patient.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30159.
    >> Share

  831. ZHU Y, Gao ZH, Liu YL, Xu DY, et al
    Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19).
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30161.
    >> Share

  832. LI H, Xiang X, Ren H, Xu L, et al
    SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19).
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30162.
    >> Share

  833. LI W, Zhang J, Xiao S, Sun L, et al
    Characteristics of health worker fatality in China during the outbreak of COVID-19 infection.
    J Infect. 2020 Apr 8. pii: S0163-4453(20)30158.
    >> Share

  834. ZENG J, Peng S, Lei Y, Huang J, et al
    Clinical and Imaging features of COVID-19 Patients: Analysis of Data from High-Altitude Areas.
    J Infect. 2020 Apr 7. pii: S0163-4453(20)30155.
    >> Share

  835. LI DL, Chen MX
    Critical patients with coronavirus disease 2019: Risk factors and outcome nomogram.
    J Infect. 2020 Apr 6. pii: S0163-4453(20)30153.
    >> Share

  836. GE R, Qi Y, Yan Y, Tian M, et al
    The role of close contacts tracking management in COVID-19 prevention: A cluster investigation in Jiaxing, China.
    J Infect. 2020 Apr 5. pii: S0163-4453(20)30144.
    >> Share

  837. SUN S, Yu K, Xie Z, Pan X, et al
    China empowers Internet hospital to fight against COVID-19.
    J Infect. 2020 Apr 3. pii: S0163-4453(20)30183.
    >> Share

    March 2020
  838. WANG L, He W, Yu X, Hu D, et al
    Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up.
    J Infect. 2020 Mar 30. pii: S0163-4453(20)30146.
    >> Share

  839. XIAO DAT, Gao DC, Zhang DS
    Profile of Specific Antibodies to SARS-CoV-2: The First Report.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30138.
    >> Share

  840. ZHANG Z, Yao W, Wang Y, Long C, et al
    Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30145.
    >> Share

  841. KWOK KO, Lai F, Wei WI, Wong SYS, et al
    Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30154.
    >> Share

  842. ZHOU B, She J, Wang Y, Ma X, et al
    The Clinical Characteristics of Myocardial injury 1 in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30149.
    >> Share

  843. FANG Z, Zhang Y, Hang C, Zhang W, et al
    Comparisons of nucleic acid conversion time of SARS-CoV-2 of different samples in ICU and non-ICU patients.
    J Infect. 2020 Mar 21. pii: S0163-4453(20)30139.
    >> Share

  844. LEI DP
    The Progression of Computed Tomographic (CT) Images in Patients with Coronavirus Disease (COVID-19) Pneumonia: The CT progression of COVID-19 pneumonia.
    J Infect. 2020 Mar 20. pii: S0163-4453(20)30151.
    >> Share

  845. HILL DKJ, Russell DCD, Clifford DS, Templeton DK, et al
    The index case of SARS-CoV-2 in Scotland: a case report.
    J Infect. 2020 Mar 20. pii: S0163-4453(20)30148.
    >> Share

  846. LEI P, Fan B, Mao J, Wang P, et al
    Comprehensive analysis for diagnosis of novel coronavirus disease (COVID-19) infection.
    J Infect. 2020 Mar 19. pii: S0163-4453(20)30142.
    >> Share

  847. LEI P, Fan B, Yuan Y
    The evolution of CT characteristics in the patients with COVID-19 pneumonia.
    J Infect. 2020 Mar 19. pii: S0163-4453(20)30143.
    >> Share

  848. DENG L, Li C, Zeng Q, Liu X, et al
    Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30113.
    >> Share

  849. CHEN J, Qi T, Liu L, Ling Y, et al
    Clinical progression of patients with COVID-19 in Shanghai, China.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30119.
    >> Share

  850. YE G, Pan Z, Pan Y, Deng Q, et al
    Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30114.
    >> Share

  851. LIU K, Chen Y, Lin R, Han K, et al
    Clinical feature of COVID-19 in elderly patients: a comparison with young and middle-aged patients.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30116.
    >> Share

  852. LIU H, Liu F, Li J, Zhang T, et al
    Clinical and CT Imaging Features of the COVID-19 Pneumonia: Focus on Pregnant Women and Children.
    J Infect. 2020 Mar 11. pii: S0163-4453(20)30118.
    >> Share

  853. IBRAHIM IM, Abdelmalek DH, Elshahat ME, Elfiky AA, et al
    COVID-19 spike-host cell receptor GRP78 binding site prediction.
    J Infect. 2020 Mar 10. pii: S0163-4453(20)30107.
    >> Share

  854. HE Y, Wang Z, Li F, Shi Y, et al
    Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30111.
    >> Share

  855. LIU Y, Chen H, Tang K, Guo Y, et al
    Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30109.
    >> Share

  856. WEN F, Yu H, Guo J, Li Y, et al
    Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.
    J Infect. 2020 Mar 4. pii: S0163-4453(20)30108.